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INTRODUCTION 
Spinal Anaesthesia is used extensively for lower abdominal and lower 
extremity surgeries, because it has distinct advantages over general Anaesthesia. 
Lignocaine and Bupivacaine are the commonly used local anesthetic agents for 
spinal anesthesia. The adjuvants like opioids and α2 agonist are sometimes 
combined with Local anaesthetic for spinal anaesthesia. The rationale for 
combining adjuvants to local anaesthetic drugs is to lower the dose of each 
agent, and maintaining analgesic efficacy whilst reducing the incidence and 
severity of side effects. 
Surgery on the uterus and other genital organs performed under spinal or 
epidural block is often accompanied by visceral pain, nausea and vomiting. 
Fentanyl in various doses when added to spinal Bupivacaine increase the 
duration of analgesia and reduce intra operative nausea and vomiting. 
Dexmedetomidine is a α2-agonist that is approved as an intra venous sedative 
and co-analgesic drug. 
Most of the clinical studies about intrathecal α2 adreno receptor agonist 
are related to clonidine. The present study was designed to evaluate the efficacy 
and adverse effects of 5μg Dexmedetomidine Vs 25μg of Fentanyl when added 
to 0.5% Hyperbaric Bupivacaine administered intrathecally in patients 
undergoing elective vaginal surgeries. 
1 
 
 
 
AIM OF THE STUDY 
To compare the effect of addition of Dexmedetomidine Vs Fentanyl to 
0.5% Hyperbaric Bupivacaine administered intrathecally for vaginal surgeries 
with respect to 
• Time to onset of sensory and motor block. 
• Duration of sensory and motor block. 
• Quality of intra operative anaesthesia. 
• Time for demand analgesia. 
• Side effects. 
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SPINAL ANAESTHESIA 
Spinal (subarachnoid/ intrathecal) anaesthesia is a form of central 
neuraxial block in which a temporary interruption of nerve transmission is 
achieved following injection of local anaesthetic and / or adjuvant solutions into 
the subarachnoid space. 
Spinal anaesthesia is one of the most frequently employed methods of 
regional anaesthesia. 
ANATOMY 
The Vertebral canal extends from the foramen magnum to the sacral 
hiatus. It is formed by the dorsal spine, pedicles and laminae of successive 
vertebrae (7cervical, 12 thoracic, 5 lumbar, and 5 sacral). The vertebrae are held 
together by a series of overlapping ligaments namely, the anterior and posterior 
longitudinal ligaments, ligamentum flavum, interspinous ligament, 
supraspinous ligament and the intervertebral discs. 
The spinal cord, a direct continuation of the medulla oblongata begins at 
the upper border of the atlas and terminates distally in the conus medullaris. 
The distal termination, because of the differential growth rates between the 
bony vertebral canal and central nervous system varies from L3 in the infant, to 
the lower border of L1 in the adult. 
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Surrounding the spinal cord in the bony vertebral column are three 
membranes- (from within to the periphery); the pia mater, arachnoid mater and 
dura mater. The pia mater is a highly vascular membrane that closely invests 
the spinal cord. The arachnoid mater is a delicate non vascular membrane 
closely attached to the outer most dura mater. 
Between the two innermost membranes is the subarachnoid space. In this 
space cerebrospinal fluid (CSF), spinal nerves, blood vessels that supply the 
spinal cord and dentate ligaments are present. Although the spinal cord ends at 
the lower border of L1 in adults, the subarachnoid space continues to S2 level. 
The outermost membrane in the spinal cord is the longitudinally organized 
fibroelastic membrane, the dura mater. This layer is the direct extension of the 
cranial dura mater and extend as the spinal dura mater from the foramen 
magnum to S2, where the filum terminale (as extension of the pia mater 
beginning at conus medullaris) blends with the periosteum of the subdural space 
which contains only small amounts of serous fluid to allow the dura and 
arachnoid move over each other. Surrounding the dura mater is the epidural 
space which extends from the foramen magnum to the sacral hiatus. Posterior to 
the epidural space is the ligamentum flavum. Immediately posterior to the 
ligmentum flavum is the interspinous ligament. Extending from the external 
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occipital protuberance to the coccyx, posterior to this structure is the 
supraspinous ligament. 
Lumbar puncture is routinely done below the L2 vertebrae down to the 
L5-S1 interspace to avoid damage to the spinal cord which ends at the lower 
border of L1 vertebrae in adults. 
PHYSIOLOGY OF SUBARACHNOID BLOCK 
Cerebrospinal fluid 
The cerebrospinal fluid (CSF) is an ultrafiltrate of blood plasma which is 
in hydrostatic and osmotic equilibrium. It is a clear, colourless fluid found in 
the spinal and cranial subarachnoid space and in the ventricles of the brain. The 
average volume in the adults ranges from 120 to 150 ml of which 35 ml in the 
ventricles, 25 ml is in the cerebral subarachnoid space and 75 ml is in the spinal 
subarachnoid space. It is secreted by the choroidal plexus at a rate of             
0.3-0.4 ml/minute. 
Physical characteristics of cerebrospinal fluid9 
PH      7.4 
Specific gravity — referred to Water 
• At body temperature   1.007 
• At 4 deg C    1.0003 
Density     1.0003 g/ml 
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Baricity     1.000 
Pressure     8-12 mm Hg / 70-80 cm H2O 
Cells      3-5 /cu.mm 
Proteins     20mg/dl 
Glucose     45-80 mg/dl 
The cerebrospinal fluid plays an important role in spinal anesthesia as a 
media for dispersion of the local anaesthetic drug to the spinal nerve. An 
important factor determining the spread of drugs in the subarachnoid space is 
the specific gravity of the injected solution compared with that of CSF. 
Mechanism of spinal Anaesthesia 
Injection of local anaesthetics into the spinal CSF allows access to sites 
of action both within the spinal cord and the peripheral nerve roots. The nerve 
roots leaving the spinal canal are not covered by epineurium and are readily 
exposed to the local anaesthetic within the CSF. Therefore afferent impulses 
leaving via the ventral nerve roots are blocked during spinal anaesthesia. Spinal 
local anaesthetics block sodium channels and electrical conduction in spinal 
nerve roots. There are also multiple potential action of local anaesthetics within 
the spinal cord at different sites. Local anaesthetics can exert sodium channel 
block within the dorsal and ventral horns, inhibiting generation and propagation 
of electrical activity10 The order in which nerve fibers are blocked in spinal 
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anaesthesia is preganglionic sympathetic B fibers followed by temperature 
fibers (cold before warmth), fibers carrying pin prick sensation, tough, deep 
pressure, and proprioceptive impulses. Recovery is roughly in the reverse order. 
Spread of LA in the subarachnoid space 
The local anaesthestic solution is diluted in the CSF and therefore its 
original concentration is of less potent than the actual solution of mass of drug 
injected. Spread is also determined by the baricity of the injected solution. 
Baricity is a ratio comparing the density of LA solution at a specified 
temperature to the density of CSF at the same temperature. A hypobaric 
solution has a baricity less than 1.0000 or specific gravity less than 1.0069. 
(mean value of CSF specific gravity). 
A hyperbaric solution has a baricity greater than 1.0000 or specific 
gravity more than 1.0069. Hypobaric and hyperbaric solutions are prepared 
from isobaric solutions by addition of various amounts of sterile distilled water 
and dextrose respectively. Isobaric solutions do not move under the influence of 
gravity in the CSF. Spread of solution and consequently height of block is not 
influenced by position of patient and is somewhat unpredictable. Hyperbaric 
solutions, being heavier than CSF, settle to the most dependent aspect of the 
subarachnoid space, which is determined by the position of the patient. In a 
supine patient, hyperbaric solutions gravitate to the thoracic kyphosis. 
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Hypobaric solution ‘floats’ up to the nerves innervating the surgical site. The 
major factors affecting height of subarachnoid block are the baricity of the local 
anaesthetic solution and the dosage (mass) of drug injected. 
Fate of Local Anaesthetics in Subarachnoid Space 
Following injection of local anaesthetic solution into subarachnoid space, 
its concentration falls rapidly. The initial steep fall is due to mixing with CSF 
and subsequent absorption into nerve roots and spinal cord. The regress of local 
anaesthetics following subarachnoid injection is primarily by vascular 
absorption with no hydrolysis or degradation taking place in the CSF. 
Depending on the type of the drug used, it is metabolized in plasma by 
pseudocholinestrease of in the liver. As duration of anaesthesia is in the part, a 
result of the rate of absorption from the subarachnoid space, the addition of a 
vasconstrictor to the local anaesthetic solution will retard absorption of the drug 
and thus increase the duration of anaesthesia. 
Indications for Subarachnoid Block 
Spinal anaesthesia can be administered whenever a surgical procedure 
can be done with a sensory level of anaesthesia that does not produce adverse 
patient outcome which includes, 
• Lower abdominal surgeries 
• lower limb surgeries 
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• urological procedures 
• obstetric procedures 
• gynaecological surgeries 
• perineal & rectal surgeries 
Contraindications for Subarachnoid Block 
An absolute contraindication for subarachnoid block is patient refusal. 
Other contraindications are: 
• local sepsis 
• uncorrected coagulopathy 
• uncontrolled blood loss/shock 
• fixed cardiac output states 
• documented allergy to local anaesthetics 
• raised intracranial pressure 
• neurological disease 
• major spine deformities/previous surgery on the spine 
• severe cardiac disease 
SPINAL ANAESTHESIA — TECHNIQUE 
The first step in the successful application of spinal anaesthesia is proper 
patient selection. This is accomplished by preanaesthetic evaluation of the 
patient through history, physical examination, laboratory data and 
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communication with the patient and surgical staff about detail of the 
communication with the patient and surgical staff about detail of the procedure. 
Suitable premedication is given to the patient before performing the 
subarachnoid block. Reliable intravenous access through a large bore 
intravenous cannula is mandatory. The administration of 500-1000 ml of [15-
20ml/kg] of crystalloid to limit the hypotension that may result from the 
sympathetic block produced by spinal anaesthesia has some merit. The 
recommended standards for airway management and emergency drugs are kept 
in readiness. Spinal anaesthesia should be administered to a cooperative patient 
who is placed on a table that can be tripped upward or downward. 
Procedure 
The spinal anaesthetic technique can be broken down into a series of 
steps, the four ‘P’s; Preparation, Position, Projection and Puncture. 
Preparation 
Preparation of the equipment and drugs is essential for performing a 
subarachnoid block. The choice of drug is based on the duration of block 
desired, the surgical procedure and patient variables. Spinal needles of various 
diameters with various types of points are available. Spinal needles fall into two 
main categories; those that cut the dura and those designed to separate the dural 
fibers. The former includes the Quincke – Babcock needle and the latter include 
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the Greene, Whitacre and Sprotte needles. In order to keep the incidence of post 
dural puncture headache to a minimum, small bore needles with a rounded non-
cutting bevel are preferred. 
Position 
The choice of position of the patient for performing the subarachnoid 
block depends on a number of factors, the proposed surgery being the most 
important. The three primary methods of positioning include lateral decubitus, 
sitting and prone positions; each with its own advantages in specific situations. 
In the lateral decubitus position, the patient is placed with his back parallel to 
the edge of the operating table nearest the anaesthesiologist, with thigh flexed 
upon the abdomen and neck flexed to allow the forehead to be as close to the 
knees as possible. The sitting position is chosen when low lumbar and sacral 
levels of anaesthesia are adequate for the surgical procedure, when obesity or 
scoliosis make identification of midline anatomy difficult in the lateral 
decubitus position or when orthopaedic problems of the hip and knee exist. The 
prone position is used primarily for the hypobaric technique for rectal and 
perineal procedures. 
Projection and Puncture 
The spinal puncture can be performed either by a midline or a 
paramedian approach, usually at the L2-L3. L3-L4 or L4-L5 interspaces. The 
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procedure is carried out under strict aseptic conditions. The patient’s back is 
widely prepared with an antiseptic solution and sterile drapes applied. A line 
from the highest point of the iliac crest passes through either the spinous 
process of L4 or the L4-L5 interspace. The midline approach with patient in 
sitting position is used in our study. Depending on the interspace and approach 
selected, a subcutaneous skin wheal is raised over the intended puncture site 
with local anaesthetic solution. If an introducer is not used, the skin and soft 
tissue are fixed against the bony landmarks which straddle the interspace by the 
second and third fingers of the non-dominant hand of the anaesthesiologist. The 
needle is inserted in midline in the middle of the interspace with bevel parallel 
to the longitudinal dural fibers. After traversing the skin and subcutaneous 
tissue, the needle is advanced in a slightly cephalad direction with the long axis 
of the vertebral column. A characteristic change in resistance occurs as the 
needle traverses the supraspinous ligament, interspinous ligament, ligmentatum 
flavum, dura and pierces the arachnoid which becomes quite recognize as 
experience is gained. The stylet is removed and appearance of cerebrospinal 
fluid at the hub of the needle confirms the correct position of the needle tip. The 
hub of the needle is firmly hold between the thumb and index finger of the 
anaesthesiologist’s non-dominant hand and the back of that hand placed against 
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patient’s back to steady the needle, while syringe containing anaesthetic 
solution is firmly attached to the needle. 
After confirming the flow of spinal fluid by aspiration, the anaesthetic 
solution is injected. The patient is placed in supine position. Cardiovascular and 
respiratory functions are monitored. Analgesia is checked by loss of sensation 
to pinprick. 
COMPLICATIONS OF SUBRACHNOID BLOCK 
Immediate 
1. Hypotension 
2. Bradycardia 
3. Toxicity due to intravascular injection 
4. Allergic reaction to local anaesthetic 
5. Hypoventilation (brain stem hypoxia) 
Late 
1. Post dural puncture headache 
2. Retention of urine 
3. Backache 
4. Meningitis 
5. Transient lesions of cauda equine 
6. Sixth nerve palsy 
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7. Anterior spinal artery syndrome 
8. Horner’s syndrome 
PHARMACOLOGY OF BUPIVACAINE 
Bupivacaine is an amide local anaesthetic, synthesized by A. F. 
Ekenstam in 1957 and brought into clinical use in 1963. 
It is produced for clinical use in a racemic mixture, containing equal 
proportions of the ‘S’ and ‘R’ enantiomers. It is supplied for clinical use as a 
hydrochloride salt. 
Chemical Structure 
Description : ± 1 — Buty-N-(2, 6-dimethylphenyl)-2-piperidine 
Decarboxamide Hydrochloride monohydrate. 
Physico-chemical Profile 
Molecular Weight (base)   - 288 
pKa      - 8.1 
Solubility in Alchohol   - 1 in 8 
Water      - 1 in 25 
Octanol /Water partition coefficient - High 
Lipid solubility    - 28 
Plasma Protein Binding   - 95% 
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Mechanism of Action 
Bupivacaine exerts its effect by inhibition of sodium channels. It acts to 
block conduction in the nerves by decreasing or preventing the large transient 
increases in permeability of the cell membrane to sodium ions that follows 
depolarization of the membrane. Bupivacaine also reduces the permeability of 
the resting nerve membrane to potassium as well as sodium ions. 
Pharmacodynamics 
Bupivacaine by virtue its pharmacological effects, has a stabilizing action 
on all excitable membranes. In the central nervous system, stimulation can 
occur producing restlessness, tremors and convulsions in overdosage. 
Bupivacaine also causes a reduction in the of automaticity of the heart. 
The clinical profile of nerve blockade produced by Bupicavaine differs 
from that of lignocaine. It is 4 times more potent than lignocaine, but the onset 
of action is slower. The duration of action is considerably longer. The sensory 
block produced by Bupivacaine tends to be more marked than the motor block. 
Pharmacokinetics 
Bupivacaine is rapidly absorbed from the site of injection. The rate of 
rise in plasma Bupivacaine concentration and the peak plasma concentrations 
obtained depend on the route of administration. There is also some inter 
individual variation and peak systemic concentrations may occur between 5 and 
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30 minute after administration. The addition of vasoconstrictor delays 
absorption and results in lower plasma concentrations of Bupivacaine. 
Pharmacokinetic Profile 14 
Volume of distribution at steady rate (Vdss)  72 litres 
Clearance       0.47 L.min 
t ½ α        2.7min 
t1/2β        28min 
t1/2γ        3.5hrs 
Metabolism 
Possible pathways for metabolism of Bupivacaine include aromatic 
hydroxylation, N-dealkylation, amide hydrolysis and conjugation. Only the N-
dealkylated metabolic  N-esmethylbupivacaine has been measured in blood and 
urine after epidural and spinal administration. The degradation of Bupivacaine 
takes place in the liver. Renal disease is unlikely to alter the kinetics of 
Bupivacaine to any great extent. Less than 10% of the drug is excreted 
unchanged in urine. 
The onset of action of Bupivacaine occurs 20 — 30 minutes after a 
peripheral nerve block and duration lasts for 8-9 hours 
Clinical Applications 
• Infiltration anaesthesia 
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• Peripheral nerve blocks 
• Central neruraxial blocks (intrathecal, epidural and caudal) 
Contraindications 
• Paracervical block (in obstetrics) 
• Known hypersensitivity to amide local anesthetics 
• Intravenous regional anaesthesia (IVRA) 
Preparations Available 
0.25%, 0.5% solutions in 10ml and 20ml vials. 
5mg/ml (0.5%) Bupivacaine and 80mg dextrose in 4 ml ampoules for 
intrathecal injection (Baricity 1.0207) 
Recommended Safe Dose 
Concentration Used 
Maximum Permitted 
Dose 
0.125%-0.5% 3mg/kg body weight 
0.75%(not to be used in obstertric 
epidurals) 
Max.over 4 Hrs—150mg 
Max.during 24Hrs-400mg 
0.5% plain / hyperbaric solution 
(intrathecal use) 
20 mg. 
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Adverse Reactions 
Adverse reactions are associated mainly with excess plasma levels of the 
drug, which may due to overdosage, unintentional intravascular injection or 
slow metabolic degradation. 
CNS Reactions 
Excitation characterized by restlessness, anxiety, dizziness, tinnitus 
blurred vision or tremors possibly proceeding to convulsions, followed by 
drowsiness, unconsciousness and cardiac arrest. 
Cardiovasular System Effects 
Part of the cardiac toxicity that occurs from high plasma concentrations 
of Bupivacaine occurs because of blockade of cardiac sodium channels. 
Accidental intravenous injection of Bupivacaine causes cardiac dysarrthymias, 
atrioventricular block, verticular tachycardia and ventricular fibrillation. 
Pregancy increases the sensitivity of cardiotoxic effects of Bupivacaine. 
Allergic Reactions 
Mainfests as urticaria, pruritus, angioneurotic edema etc. Cross 
sensitivity among members of amide type local anaethetics has been reported. 
PHARMACOLOGY OF Dexmedetomidine 
Dexmedetomidine is a highly selective α2 adrenergic agonist that 
produces sedation, hypnosis and analgesia. 
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STRUCTURE OF DEXMEDETOMIDINE 
 
 
HISTORY:- 
The initiation of the use α2 agonists in anaesthesia resulted from 
observations made in patients during anaesthesia who were receiving clonidine 
therapy. Dexmedetomidine was introduced in clinical practice in 1999. It was 
approved by FDA as a short-term [<24 hours] sedative for mechanically 
ventilated ICU patients. 
CHEMISTRY:- 
- 4[cs]-alpha,2,3-Trimethylbenzyl)imidazole 
- Dexmedetomedine Hydrochloride is the s-enantiomer of medetomidine 
and is chemically described as: 
-  (+)-4-(s)-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazolemonohydrochloride 
Molecular formula  : C13H16N2.Hcl 
Molecular Weight   : 236.74 
PHARMACOLOGICAL PROFILE: 
It is a highly selective α2 adrenergic agonist. It shows a high ratio of 
specificity for the α2 receptor [α2:d1, 1600:1] compared with clonidine [α2:d1 
200:1] making it a complete α2 agonist. Dexmedetomidine belongs to the 
imidazole subclass of α2 agonists. Dexmedetomidine is the active s-enantiomer 
of meditomedine. It is highly water soluble and is available as a parenteral and 
preservative free formulation. 
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PHARMACOKINETICS: 
Dexmedetomidine has a rapid distrubtion halflife-6 minutes. It is 94% 
protein bound and its concentration ratio whole blood and plasma is 0.66. 
Metabolism: 
Dexmedetomidine undergoes biotransformation by conjugation [41%], 
N-methylation [21%] or hydroxylation followed by conjugation in liver. The 
inactive metabolites excreted in urine and faces. The elimination half-life of 
Dexmedetomidine is 2 to 3 hours, with a context. Sensitive half time ranging 
from 4 mins after a 10 minute infusion to 250 minutes after an 8-hour infusion. 
Pharmacokinetics are similar in young adults and elderly. 
Mechanism of Action: 
Dexmedetomidine is a highly selective α2 agonist. There are 3 types of 
α2 adrenoreceptors in humans: α2A, α2B, d3C. The α2A adrenoreceptors are 
primarily distributed in the periphery where as α2B and α2C receptors are 
located in the Brain and Spinal cord. 
Presynaptic activation of α2 adrenoreceptors inhibits the release of nor-
epinephrine. 
Post synaptic activation of α2-adrenoreceptors in the central nervous 
system inhibits sympathetic activity and decreases blood pressure and heart rate 
producing sedation and anxiolysis. 
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Analgesia is produced through binding of dexmedetomidine< to α2 
adrenergic receptors in the spinal cord. 
The overall response to α2 adrenoreceptor agonists is related to the 
stimulation of α2 adrenoreceptors located in the CNS and spinal cord. 
Dexmedetomidine produces sedation and hypnosis by action on α2 
receptors in the locus ceruleus and analgesic effect by acting at α2 receptors 
with in the locus ceruleus and with in the spinal cord. 
ACTIONS: 
Effects on the central nervous system: 
SEDATION; 
The α2 agonists through the endogenous sleep-promoting pathways to 
exert their sedative effect. 
If produces unique sedative quality-yet arousable, alert and able to 
respond without becoming uncomfortable. Despite sound levels of sedation 
with Dexmedetomidine, there is limited respiratory depression. Providing wide 
safety margins. 
ANALGESIA: 
The analgesic effects of Dexmedetomidine are complex. They have an 
analgesic effects when injected through the intrathecal or epidural route. The 
primary site of action is thought to be the spinal cord. 
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Systemic use of Dexmedetomidine shows narcotic sparing narcotic 
requirements were reduced by 50% in patients receiving Dexmedetomidine. But 
the effects are inconsistent. 
OTHER EFFECTS: 
Dexmedetomidine in animal models of incomplete cerebral ischaemia 
and reperfusion reduces cerebral narcosis and improves cerebral outcome by 
reducing the intra cerebral catecholamine outflow and the reduction of the 
excitatory neurotransmitter glutamate during injury. 
Dexmedetomidine also reduces muscle rigidity after high-dose opioid 
administration. 
EFFECTS ON THE RESPIRATORY SYSTEM: 
Dexmedetomidine of concentrations producing significant sedation 
reduces minute ventilation but retains hyper capnic ventilator response. The 
changes in ventilation appeared similar to those observed during natural sleep. 
Dexmedetomidine has been implicated in blocking histamine – induced 
broncho constriction in dogs. 
EFFECTS ON THE CARDIOVASCULAR SYSTEM: 
The basic effects of Dexmedetomidine on the cardiovascular system are 
decreased heart rate, decreased systemic vascular resistance and indirectly 
decreased myocardial contractility and systemic Blood pressure. 
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The effects of Dexmedetomidine on blood pressure shows a Biphasic 
response an initial increase in Blood pressure that occurred of 5 mins after 
administration [due to the vaso constrictive effects of Dexmedetomidine on 
peripheral α2 adrenoreceptors] followed by decreased in Blood pressure due to 
action on central α2 adrenoreceptor activity. 
The incidence of Hypotension and Brady cardia may be related to the 
administration of loading dose omitting the loading dose or not giving more 
than 0.4μg/kg reduces the incidence of Hypotension. Giving the loading dose 
over 20 minutes also minimizes the transisent Hypertension. 
DOSAGE AND ADMINISTRATION: 
Dexmedetomidine is supplied in 2ml ampoule, 100μg-ml & 1ml ampoule 
50μg/ml. Preservative free 
• Loading dose  – 0.5  – 1.0μg/kg over to minutes 
• Maintenance dose  – 0.3  – 0.7μg/kg/hr 
USES: 
Dexmedetomidine has been approved as a short-term sedative for adult 
intubated patients in ICU. 
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1. INTENSIVE CARE UNIT: 
• Dexmedetomidine has following advantages for sedation in mechanically 
ventilated patients. Decreased requirement for opioids >50% when 
compared with propofol or Benzobiazepines. 
• Providing adequate sedation with minimal respiratory depression. Can be 
used when weaning patients from ventilator. 
• Dexmedetomidine has been used in the treatment of alcohol and drug 
withdrawal of narcotics, benzodiazepines, alcohol and recreational drugs. 
2. Anaesthesia: 
• Dexmedetomidine at doses of 0.3-0.67μg/kg given 10-15 minutes before 
induction attenuates the hemodynamic response to infubation. 
• As a premedication 2.5μg/kg IM. 
• Used for securing the airway during fibreoptic infubation. 
• Sedation during regional Anaesthesia. 
• As an anaesthetic adjuvant in Bariatric surgery, sleep apnea patients. 
Vascular surgery, CABG surgery, Craniotomy ancurysm, evoked 
potential study, thoracic surgery. 
CONTRA INDICATIONS: 
• Infusions over 24 hrs 
• In caesarean deliveries, as the safety has not been studied 
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• Patients with preexisting Bradycardia and related Bradyarythmias. 
• Patients with impaired ventricular function –Ef<30%] 
• Hypovolemic or Hypotensive patients. 
• Patients with raised intra cranial tension. 
                             FENTANYL   PHARMACOLOGY 
Fentanyl  
Fentanyl is a potent lipophilic synthetic opioid, μ receptor agonist with a 
short onset time and moderate duration of action. Fentanyl citrate is the 
synthetic parent opioid from which sufentanil and alentanil are derived. 
Chemistry 
Fentanyl citrate (sublimaze, durageric, duragesic) 
C22H28N2OC6H8O7 
N-phenyl-N-[1 (2-phenylethyl)-4piperidinyl] propanamide citrate 
The phenylpiperidine (synthetic) opioid fentanyl skeleton structure. 
Molecular weight (free base)   528.5(336.5) 
pKa (amino)     8.43 
Solubility 
in alcohol     1 in 140 
in water     1 in 40 
Octonol / water partition coefficient  955 
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Fentanyl is a μ agonist. It has a more rapid onset and shorter duration of 
action than morphine. The greater potency and more rapid onset of action 
reflect the greater lipid solubility of fentanyl compared with that of morphine. 
Fentanyl produces dose related analgesia. Small doses of 0.5-3.0μgkg-1 
may be used as a supplement in spontaneously breathing anaesthetized patients. 
Doses of 5.0μgkg-1 upward will suppress somatic and autonomic responses to 
surgical stimulation in ventilated patients. 
Doses of 50μgkg-1 in conjunction with muscle relaxant and mechanical 
ventilation, may be used to induce and maintain anaesthesia. 
Fentanyl is a potent respiratory depressant and reduces brain stem 
respiratory responsiveness to CO2 and peripheral chemoreceptor input during 
hypoxemia. 
Fentanyl exerts minimal effects on the circulation. There is a vagally 
mediated bradycardia and a slight all in systemic vascular resistance. 
Skeletal muscle rigidity and clonic movements can hinder mechanical 
ventilation. This effect is reversed by naloxone and overcome by neuromuscular 
blocking drugs. Rigidity may also occur during emergence from anaesthesia. 
High dose fentanyl obtunds the metabolic and hormonal response to 
surgery. 
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There is a reduction in metabolic activity following fentanyl and hence in 
oxygen consumption. Nausea and vomiting are the result of stimulation of the 
chemoreceptor trigger zone. Cough suppression, pupillary constriction and 
itching of the nose also occur. 
Fentanyl has been found to significantly increase intracranial pressure in 
patients with severe head injury. Fentanyl also significantly decreases cerebral 
perfusion pressure. 
Fentanyl may cause a rise in biliary intraluminal pressure. 
Fentanyl will reduce intraocular pressure independent of changes in 
arterial blood pressure. 
Relative contraindications for fentanyl are 
1. Hypovolemia 
2. Respiratory inadequacy 
3. Raised ICP 
Pharmacokinetics 
A three-compartment model is typically used to describe plasma fentanyl 
concentration decay. The lungs exert a significant first pass effect and 
transiently take up approximately 75 percent o an injected dose of fentanyl. 
As is typical of the fentanyl both volume of distribution (3-6Lkg-1) 
and clearance (10-20 mlkg-1 min-1) are high 
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Approximately 80% of fentanyl is bound to plasma proteins, and 
significant amount (40%) are taken up by red blood cells. As the pKa of 
fentanyl is high (8.4) at physiologic pH, it exists mostly in the ionized from (> 
90%). Fentanyl’s lipid solubility is also high, a finding that explains in part its 
large volume of distribution. The tissue/blood partition coefficient of fentanyl is 
found to be 2-30 fold higher than those of alfentanil. Because fentanyl is 
distributed so widely in the body, it must ultimately be returned to the blood to 
be metabolized in the liver. Fentanyl is relatively long acting, in large part 
because of its widespread distribution in body tissues. 
Fentanyl is primarily metabolized in the liver by β-dealkylation and 
hydroxylation. Fentanyl has a high hepatic clearance (approaching hepatic 
blood flow) and a high hepatic extraction ratio (approaching 1.0). Metabolism 
begins to appear in the plasma as early as 1.5 min after injection. Norfentanyl, 
the primary metabolite, is detectable in the urine for upto 48 hours after IV 
fentanyl in humans. The activity of fentanyl’s metabolites is unclear, but it is 
thought to be minimal. Little fentanyl is excreted in the urine unchanged. 
Factors that alter pharmacokinetics and pharmacodynamics 
• Age: The elimination of fentanyl in neonates is prolonged. With 
advanced age although pharmacokinetics changes may play a minor role, 
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• Weight: Fentanyl pharmacokinetics is not grossly different in lean versus 
obese subjects. 
• Renal failure: For the fentanyl congeners the clinical importance of 
kidney failure is less marked. 
• Hepatic failure: Reduction in liver blood flow that result from either 
liver disease or some other disorder will delay the decline of fentanyl 
plasma concentration. 
• Cardiopulmonary bypass: Fentanyl pharmacokinetics is extensively 
altered by CPB. 
• Acid-base changes: Acidosis increase ionized fentanyl in the interstitial 
space, draws unionized fentanyl out of the intracellular compartment, 
where a 13-fold accumulation of fentanyl occurs, further augmenting 
opioid effects, i.e. ventilatory depression. 
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Review of Literature 
1. Subhi M. Al-Ghanem et al studied to evaluate the onset and duration of 
sensory and motor block as well as operative analgesia and adverse effects of 
DXM or fentanyl given intrathecally with plain. Bupivacaine for spinal 
anaesthesia. 78 patients were scheduled for vainal hysterectomy, vaginal wall 
repair and tension free vaginal tape were prospectively studied patients were 
randomly allocated to receive intrathecally either 10mg of isobaric bupivacaine 
plus 5μg of DXM [Group [n=38] or 10mg of isobaric bupivacaine plus 25μg of 
fentanyl [Group F n=38], the onset time reach peak sensory and motor level, the 
regression time for both sensory and motor Blockade, hemodynamic changes 
and side effects were recorded. Patients in Group-D had significant longer 
sensory and motor block times than patients in Group-F the mean time of 
sensory regression to s1 was 274±73 min in group D and 179±41 min group F 
[p < 0.001]. The regression time of motor block to reach modified Bromage 0 
was 240±60 min in group D and 179±47 min in Group F [p < 0.001]. The 
results suggested that 10mg plain Bupivacaine with 5μg DXM produces 
prolonged motor and sensory block compared with 25μg Fentanyl. 
2. Mahmoud M. Al-mustafa et al studied to determine the effect of adding 
DXM to Bupivacaine for neuraxial anaesthesia 66 patients were randomly 
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assigned in 3 groups each receiving spinal bupivacaine 12.5mg combined with 
Normal saline (Group N), DXM 5μg [Group D5] & DXM 10mg [Group D10]. 
The onset time to reach T10 sensory and Bromage 3 motor block and the 
regression times to reach S1 sensory level and Bromage 0 motor scale were 
recorded. The mean time of sensory Block to reach the T10 dermatome was 
4.7+/-2.0 minutes in D10 group, 6.3+/-2.7 minutes in D5 and 9.5+/-3.0 minutes 
in group N. The mean time to reach Bromage 3 scale was 10.4+/-3.4 minutes in 
Group D10 13.0+/-3.4 minutes D5 and 18.0+/-3.3 min in Group N. The 
regression to Bromage 0 was 302.9+/-36.7 min in D10, 246.4+/-25.7 min in D5 
and 140.1+/-32.3 minutes in Group N. The conclusion was dexmedetomidine 
has a dose dependent effect on the onset and regression of sensory and motor 
block when used as an adjuvant to Bupivacaine in spinal anaesthesia. 
3. Kanazi et al studied to compare the onset and duration of sensory and motor 
block as well as the hemodynamic changes and level of sedation following 
intrathecal bupivacaine supplemented with either DXM or clonidine 60 patient 
received 12mg of 0.5% Bupivacaine [n=20], Group B, Group D received 12mg 
0.5% Bupivacaine with 3μg of DXM and group C received 12mg of 0.5% 
Bupivacaine supplement with 30μg of clonidine. The onset times to reach peak 
sensory and motor levels and the sensory and motor regression times, were 
recorded. Hemodynamic changes and the level of sedation were recorded.  
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Patients in Groups D and C had a significantly shorter onset time of motor 
block and significantly longer sensory and motor regression times than patients 
in Group B. The mean time of sensory regression to the S1 segment was 
303±75 min in Group D, 272±38 min in group C and 190±48 min in group B. 
The regression of motor block to Bromage 0 was 250±76 min in group D, 
216±35 min in group C and 163±47 in group B [p valve < 0.001]. The onset 
and regression times were not significantly different between groups D and C. 
The mean arterial pressure, heart rate and level of sedation were similar in the 
three groups intra operatively and post-operatively. DXM (3μg) or clonidine 
(30μg), when added to intrathecal Bupivacaine, produces a similar prolongation 
in the duration of the motor and sensory block with preserved hemodynamic 
stability and lack of sedation. 
4. Ibrahim. F.A. Khalifa et al studied the effect of adding intrathecal 
dexmedetomidineVs sufentanyl to heavy bupivacaine for post-op analgesia in 
patients undergoing inguinal hernia repair. 50 ASA Grade I/II patients, 
scheduled for elective inguinal hernia repair with 5μg of DXM and 5μg of 
sufentanyl with heavy bupivacaine 0.5% 2ml onset and duration of sensory and 
motor blockade, surgical condition and side effects were assessed. The duration 
of effective post-operative analgesia as assessed by VAS was not statistically 
significantly in between both groups. Cardio vascular and respiratory stability 
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was maintained with no significant incidence of side effects in either group. The 
addition of DXM 5μg and sufentanil 5μg intrathecally provide improved 
postoperative analgesia and hemodynamic stability Dexmedetomidine prolongs 
the post-op analgesia as sufentanil but with minimal side effects. 
5. Antonio Mauro Vieira et al studied the analgesia and sedation promoted by 
clonidine or DXM associated to epidural ropivacaine, in the post-operative 
period to subcoastal cholecystectomy 40 pts of ASA I & II received clonidine 
150μg to epidural ropivacaine 0.75% [20ml], DXM 2μg/kg-1 associated to 
epidural ropivacaine 0.75% 20ml. Analgesia and sedation were evaluated 216 
and 24 hours anesthetic recovery. Both groups present some grade of sedation 
in the moments 2 and 6 hours, with statistically significant difference between 
the two moments for DXM group. There has bee analgesia in 6 and 24 hrs in 
the DXM group; in the clonidine group, this statistically significant difference 
was observed between the periods of 2 and 6 hours and between 2 and 24 hours. 
The conclusion was allowed to conclude that the association of clonidine or 
DXM to 0.75% ropivacaine induces analgesia and sedation in 2 and 6 hours 
after anesthetic recovery in patients submitted to subcostal cholecystectomy and 
that clonidine promotes more prolonged analgesia. 
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6. Saadway et al4 studied the effect of DXM on the characteristics of 
Bupivacaine in a caudal block in pediatrics. 66 children undergoing unilateral 
inguinal hernia repair/orchidopexy were allocated randomly and Group B 
(n=33) received a caudal injection of Bupivacaine 2.5mg/ml, 1ml/kg; Group 
BD(n=33) received the same dose of Bupivacaine mixed with Dex 1μg/kg 
during sevoflurane anaesthesia. Processed EEG [BIS], heart rate, Blood 
pressure, pulse oximetry and end-tidal sevoflurane were recorded every 5 min. 
The characteristics of emergence, objective pain score, sedation score and 
quality of sleep were recorded post-operatively. Duration of analgesia and 
requirement for additional analgesics were noted. The results were the end-tidal 
sevoflurane concentration and the incidence of agitation were significantly 
lower in the BD group [p < 0.05 ]. The duration of analgesia was significantly 
longer (p < 0.001) and the total consumption of rescue analgesia was 
significantly lower in Group BD compared with Group B (p < 0.01). Group BD 
had better quality of sleep and a prolonged duration of sedation ( p < 0.05) and 
the conclusion was caudal Dexmedetomidine seems to be a promising adjunct 
to provide excellent analgesia without side effects over a 24hr period. It has the 
advantage of keeping the patients calm for a prolonged time. 
7. El. Hennawy Am et al studied the addition of clonidine or dexmedetomidine 
to Bupivacaine prolongs caudal analgesia in children. Undergoing lower 
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abdominal surgeries. 60 patients [6 months to 6 years] were evenly and 
randomly assigned into three groups in a double-blinded manner. After 
sevoflurane in oxygen anaesthesia, each patient received a single caudal dose of 
bupivacaine 0.25% [1ml kg (-1)] combined with either DXM 2μg/kg in normal 
saline 1ml, clonidine 2μg/kg in normal saline 1ml or corresponding volume of 
normal saline according to group assignment. Hemodynamic variables, end-
tidal sevoflurane and emergence time were monitored. Postoperative analgesia, 
use of analgesics and side effects were assessed during the first 24 hr. The 
results were the addition of DXM or clonidine to caudal bupivacaine 
significantly promoted analgesia time [median [95% confidence internal c1]; 16 
(14-18) and 12(3-21)h, respectively] than the use of sevoflurane and emergence 
time were monitored. Postoperative analgesia, use of analgesics and side effects 
were assessed during the first 24 hr. The results were the addition of DXM or 
clonidine to caudal bupivacaine significantly promoted analgesia time [median 
[95% confidence internal c1]; 16 (14-18) and 12(3-21)h, respectively] than the 
use of Bupivacaine alone [ median (95%c1); 5 (4-6)h] with p<0.001. However, 
there was no statistically significant difference between dexmedetomidine and 
clonidine as regards the analgesia time (p=0.796). The conclusion was addition 
of DXM or clonidine to caudal bupivacaine significantly promoted analgesia in 
children undergoing lower abdominal surgeries with no significant advantage of 
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dexmedetomidine over clonidine and with out an increase in incidence of side 
effects. 
8. Salgado PF et al studied to evaluate clinical characteristics of epidural 
anesthesia performed with 0.75% ropivacaine associated with dexmedetomidine. 
48 patients scheduled for hernia repair or varicose vein surgeries under epidural 
anesthesia participated in this study. They were assigned to: control group 
(n=20), 0.75% ropivacaine, 20ml (150 mg); and dexmedetomidine Group 
(n=20) 0.75% ropivacaine 20ml (150 mg) plus DXM 1mg/kg-1. The following 
variables were studied: total analgesic block onset time, upper level of analgesia, 
analgesic and motor block duration time, intensity of motor block, state of 
consciousness, hemodynamics post operative analgesia and incidence of side 
effects. The result was epidural dexmedetomidine did not affect the onset time 
or upper level of anesthesia (p > 0.05) however it prolonged sensory and motor 
block duration time (p < 0.05) and post operative analgesia (p < 0.05) and also 
resulted in a more intense motor block (p < 0.05). Values of Bispectral index 
were lower in DXM Group (p < 0.05). There was no difference in incidence of 
Hypotension and Bradycardia (p > 0.05). Occurence of side effects (shivering, 
vomiting and sp02 < 90%) was low and similar between groups (p > 0.05). The 
conclusion was there is a clear synergism between epidural DXM and 
ropivacaine. 
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9. Seewal R et al studied the effect of adding various doses of fentanyl to 2.2ml 
of Bupivacaine (0.5% Hyperbaric] for spinal anaesthestic in non-obstetric 
population undergoing superficial lower abdominal surgery. 60 patients 
received spinal anaesthetic with 2.2 ml of bupivacaine [0.5% Hyperbaric] and 
saline [control group], or Fentanyl 10, 20, 30 or 40 microgram. The volume of 
injected drug was kept constant at 3 ml by adding preservative free normal 
saline for blinding purposes. Subarachanoid block characteristics, drug-related 
side effects and post-operative analgesia requirements were assessed and 
recorded. Results showed a significant improvement in quality and duration of 
analgesia occurred in study groups compared with the control group p < 0.05. 
However no improvement in analgesia occurred when the dose of fentanyl 
added was increased from 10 to 20, 30, 40 microgram. Conclusion was study 
group significantly improves the quality and duration of analgesia. Seewal R – 
Effect of addition of various doses of fentanyl intrathecally to 0.5% Hyperbaric 
Bupivacaine on perioperative analgesia and subarachanoid block characteristics 
in lower abdominal surgery. 
10. Bogra J, srivastara P et al studied the synergistic effect of intrathecal 
fentanyl and bupivacaine in spinal anaesthesia for caesaran section there by 
reducing the dose, & side effects, caused by higher doses of intrathecal 
bupivacaine in cesarean section. 120 patients divided in to 6 groups, identified 
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as B8, B10, B12.5, and 12.5mg of bupivacaine and FB8, FB10, FB 12.5 mg 
received a combination of 12.5μg intrathecal fentanyl respectively. The 
parameters taken into consideration were visceral pain, hemodynamic 
instability, intraoperative sedation, intraoperative and post-operative shivering 
and post operative pain. The results were the onset of sensory block E0 T6 
occurred faster with increasing bupivacaine doses in bupivacaine only groups 
and bupivacaine – Fentanyl combination groups. Lower concentrations of 
bupivacaine alone could not completely removed the visceral pain. Blood 
pressure declined with the increasing concentration of Bupivacaine and 
Fentanyl. Incidence of nausea and shivering reduces significantly whereas, the 
post operative pain relief and hemodynamics increased by adding fentanyl. 
Conclusion was there is synergistic, potentiating effect of fentanyl on 
bupivacaine in spinal anesthesia for cesarian section is presented, Fentanyl is 
able to reduce the dose of bupivacaine and therefore is harmful effects. 
11. Biswas B.N. et al. (2002) conducted a study on forty healthy women of 
ASA Gr I Scheduled for elective caesarean section. They were randomly 
allocated to receive 2 ml of 0.5% inj Bupivacaine (hyperbaric) with 0.25 ml of 
normal saline (Group A n = 20) or 0.25 ml (12.5 µg) fentanyl with (using a 
tuberculin syringe) (Group B n = 20) 2 ml of 0.5% inj Bupivacaine (hyperbaric). 
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Pulse rate, blood pressure, respiratory rate and foetalheart rate were recorded. 
Patients were prehydrated with 15 ml kg-1 Ringers lactate solution before spinal 
anaeshthesia. The onset and duration of sensory block was assessed by pinprick 
method. Time taken from intrathecal injection to the highest level of sensory 
block and sensory regression to the L1 dermatome were recorded. The onset and 
duration of motor block was noted. Grading of motor block was done as per 
Bromage score. Pain was evaluated using a standard 10 cm linear visual analog 
scale (VAS). The duration of complete analgesia (Time from SAB to first report 
of pain) and time of effective analgesia (Time from subarachnoid injection to 
first doses of rescue analgesic) were recorded. Vital parameters and adverse 
effects, i.e. pruritus, nausea, vomiting, shivering were recorded. Every 2 
minutes for first 20 minutes, then at 15 minutes interval for remainder of 
operation and thereafter at 30 minutes interval until patient complained of pain. 
APGAR scores were recorded at 1 and 5 minutes after delivery of baby. The 
highest sensory level achieved were T7 (T6-T8) and T5 (T4-T6) in group A and B 
respectively. In fentanyl group the time taken for sensory level to regress to S1 
dermatome were prolonged but duration of motor blocks was not prolonged. 
12. Sahar M Siddik Sayyid et al. (2002) conducted a study on 48 parturients 
scheduled for elective caesarean delivery. Patients were randomized double 
blinded. Patients were all classified as ASA physical status of I and II and had 
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no contraindication to spinal anaesthesia. The 48 subjects were allocated into 
two groups by using sealed envelope technique. The IT fentanyl group received 
12 mg hyperbaric bupivacaine 0.75% and 12.5 µg of IT fentanyl (23 patients). 
The IV fentanyl group received 12 mg of hyperbaric bupivacaine 0.75% alone 
(25 patients), mix with CSF to achieve the same volume.  In the OT room 
patient preloaded with 500 ml of polygeline (hemacel). LP was done in sitting 
posture. Immediately after intrathecal administration of drug, 12.5µg inj 
fentanyl IV given in the IV fentanyl group. Immediately after SAB patient was 
put in a supine position with 15°-20° left lateral tilt and 5L oxygen given via 
mask. Blood pressure, pulse rate and SPO2 was measured every minute until 
delivery of the baby and at the 3 min interval until the end of the surgery. 
Whenever the systolic BP falls 20% below baseline 5 mg of IV ephedrine 
administered. Sensory block assessed by pinprick method every minute until 
block reached T6 dermatome. There after every 2 min until the maximum 
sensory block level was confirmed. 
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MATERIALS AND METHODS 
This study was conducted at the Kasturbai Gandhi memorial Government 
Hospital, Chennai-600 005 between June 2010 - August 2010 on 60 patients of 
ASA physical status I undergoing Elective adult surgical patient posted for 
vaginal wall repair & Vaginal Hysterectomy under subarachnoid block. This 
study was done after Government General Hospital Ethical committee approval 
and a written informed consent obtained from all the patients included in this 
study. 
Study Design 
This study was done in a prospective double blinded randomized manner. Each 
group consisted of thirty patients. 
Group D 
Patients in this group received 2.8 ml of 0.5% hyperbaric bupivacaine + 5μg 
[0.5 cc] of preservative free Dexmedetomidine to a total volume of 3.2 ml 
intrathecally. 
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Group F 
Patients in this group received 2.8ml of 0.5% hyperbaric bupivacaine + 25μg 
[0.5 cc] of Fentanyl to a total volume of 3.2ml intrathecally. 
The final volume of injected solution was 3.2ml in both groups. 
In this study 0.5% hyperbaric bupivacaine in 8% dextrose, Dexmedetomidine 
hydrocholoride 50μg/0.5ml and preservative free fentanyl 50μ/1ml. All 
solutions were prepared by the OT incharge anaesthesiologist under strict 
aseptic precautions, uninvolved in the administration of SAB or in the 
observation of results. 
Selection of Cases: 
Inclusion criteria: 
•  Patients in the age group of 30 and above undergoing elective vaginal 
hysterectomy and vaginal wall repair. 
•  ASA physical status I 
•  Who have given valid informed consent 
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Exclusion criteria: 
•  Not statisfying inclusion criteria. 
•  Contra indication to SAB. 
•  Hypersensitivity to the study drug. 
•  Renal or Hepatic dysfunction 
•  Bleeding diasthesis 
•  Uncontrolled labile Hypertension & Diabetes mellitus. 
PRE ANAESTHETIC EVALUATION 
Patients included in this study underwent through preoperative evaluation 
which included the following 
History 
History of underlying medical illness, previous surgery and hospitalization. 
Physical examination: 
1. Vital signs 
2. Height and Weight. 
3. Examination of CVS, RS, CNS, Spine 
4. Airway assessment. 
43 
 
 
 
Investigations: 
Hb, BT, CT, RFT, Blood grouping & Typing, ECG, CXR, were done. Patient 
who satisfied the inclusion criteria were explained about the nature of the study 
and the anaesthetic procedure and written informed consent were obtained from 
all patients included in the study. 
PRE LOADING: 
In the premedication room pulse rate, BP, RR and sp02 was noted. An IV line 
was secured with 16G cannula. Preloading done with RL 500ml-1000ml] over 
20-30 mts. 
Technique 
In the OT appropriate equipment for airway management and emergency drugs 
were kept ready. Patient was shifted from the premedication room to OT. The 
horizontal position of the operating table was checked and the patient was 
placed on it. NIBP, SP02, ECG leads were connected to the patient. Pre 
operative base line systolic and diastolic BP, PR, SP02 and RR were recorded. 
The anesthesiologist who were unaware of the drug combination performed the 
SAB and made observations in all the patients involved in the study. A midline 
lumbar puncture was performed using a 25G Quincke needle in Right lateral 
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position. Then patient was placed in supine position. The time of intrathecal 
injection was considered as 0 and following parameter were observed. 
Sensory Block 
Sensory block was assessed by loss of sensation to cold by cold alcohol swab 
along the mid clavicular line bilaterally, immediately after intrathecal injection 
and continued every 15sec till loss of cold sensation at T10 level till it reaches 
peak [T6 level]. The level of sensory block was noted at the end of the surgery 
and there after assessment was carried out at 15 mts interval till return of cold 
sensation at s1 dermatome, duration of sensory block was taken as the time 
from subarachanoid injection to return of cold sensation to s1. 
Motor block 
Motor block was assessed using modified BROMAGE Score 
Bromage 0 – Patient is able to move the hip, knee and Ankle 
Bromage 1 – Patient is unable to move the hip, but is able to move knee & 
ankle. 
Bromage 2 – Patient is unable to move hip & knee but able to move ankle 
Bromage 3 – Patient is unable to move hip, knee and ankle. 
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Assessment of motor block was started immediately after the intrathecal 
injection. It was tested every 15 seconds till peak motor block Bromage score 
was reached. The regression time for sensory and motor block were recorded in 
PACU. 
Vital Signs and side effects 
The systolic and diastolic BP, RR, PR & Sp02 were recorded every 1mt for 
5mts and thereafter every 5mts throughout the intra operative period. The above 
vital signs at the completion of surgery were noted. Hypotension defined as fall 
in systolic BP > 30% from baseline or MAP < 60mm of Hg. This was managed 
with Inj. Ephedrine 6mg increments. Bradycardia was defined as heart rate 
<50/mt and this was managed with Inj. Atropine 0.01mg/kg iv. Respiratory 
depression defined as RR <8/mt and or Sp02 < 85%. This was planned to be 
managed with bag and mask ventilation or intubation and IPPV if necessary. 
Blood loss more than the allowable loss was replaced with blood. Vomiting was 
treated with Inj. Emeset 4mg iv. Pruritus was noted. Since this is a benign 
subjective symptom which is under reporting and usually need no treatment and 
need for any intra-op Analgesia was noted. 
The occurrence of sedation were assessed using Ramsay sedation scale. 
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Level 1; Anxious and agitated or restless or both 
Level 2; co-operative, oriented & calm 
Level 3; Respond to commands only 
Level 4; Exhibiting Brisk response to light glabellar tap or loud auditory 
stimulus 
Level 5; Sluggish response 
Level 6; No response. 
Assessment of pain and duration of analgesia 
Pain was assessed by verbal rating score 
0-No pain. 
1-mild pain. 
2-Moderate pain. 
3-Severe pain. 
Quality of surgical anaesthesia: 
Surgical ananesthesia was graded as excellent if there was no complaint of pain 
at any time during surgery. Good if there was minimal pain or discomfort which 
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was relieved by a small dose of iv pentazocine 0.5mg/kg and poor if GA has to 
be administered. 
Assessment in PACU: 
The patient was shifted to the PACU after completion of surgery. The vitals 
signs were recorded till the regression of both motor Block [Bromage 0] & the 
sensory block [s1]. 
PACU pain was assessed every 15 minutes. When the patient reaches the pain 
score 2 Inj. Diclofenac 75mg Im was given. Duration of effective analgesia was 
defined as the time interval between onset of SAB and the time to reach pain 
score-2. 
Patient were shifted to post operative ward after complete resolution of motor 
blockade. 
Statistical analysis 
The descriptive statistics of the variables studied as represented as two-way 
tables. The categorical factors are represented by the number and Frequency 
[%] of cases. The continuous variable measures of central frequency [like 
median, mean, mode] and deviation [SD and range]. The difference in the 
proportion are tested for statistical significance using non parametric chi-square 
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test for variable measured on nominal scale. When testing for two factors the 
mann-whitney ‘v’ or Wilcoxon two sample test [by kruskal-Wallis ‘H’ test 
which is equivalent to chi-square] is used. For variables measured on a 
continous scale, one way analysis of variance is employed. 
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OBSERVATION AND RESULTS 
This study was conducted at the kasturbai Gandhi Government Hospital 
Chennai, sixty (60) patients were included in this double blinded randomized 
controlled study. The patients were divided into two groups. Patients in Group 
F received 2.8ml [13 mg] of 0.5% Hyperbaric Bupivacaine plus 25μg [0.5cc] of 
Fentanyl and patients in Group D received 2.8ml [13mg] of 0.5% Hyberbaric 
Bupivacaine plus 5μg [0.5cc] of Dexmedetomidine (preservative free). Final 
volume of injected solution was 3.2cc in both groups. 
STATISTICS 
Demographic data: The two groups were comparable with respect to their age, 
height and weight. There was no statistically significant difference among two 
groups in demographic aspects [Table No:- 1, 2, 3] 
TABLE No:-1 DISTRIBUTION OF MEAN AGE [YEAR] BY GROUPS 
Parameters Group F Group D ‘P’ Value 
No. of Cases 30 30 
0.17 
 
Mean 44.60 47.07 
S.D 6.981 6.736 
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Table No:-2 DISTRIBUTION OF MEAN HEIGHT [cms] by groups 
Parameters Group F Group D ‘P’ Value 
No. of Cases 30 30 
0.35 
 
Mean 161.87 158 
S.D 6.447 4.5008 
Table No:-3 DISTRIBUTION OF MEAN WEIGHT [kgs] by groups 
Parameters Group F Group D ‘P’ Value 
No. of Cases 30 30 
.66 
 
MEAN 62.5 59.73 
S.D 7.386 6.18 
Diagnosis in both groups: Both groups were similar in respect of Diagnosis 
and ASA. [p < 0.78] which is not statistically significant. [Table No:- 5] 
Type of surgeries in both groups: 
Both groups were similar in types of surgeries and statistically no 
significant difference among two groups p < 0.79 [Table No:- 6] 
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Table No:-4 DISTRIBUTION OF MEAN DURATION OF SURGERY [in 
mins] by groups 
Parameters Group F Group D ‘P’ Value 
No. of Cases 30 30 
0.268 
 
MEAN 75.90 74.68 
S.D 12.221 11.98 
Table No:-5 DISTRIBUTION OF DIAGNOSIS 
PARAMETERS Group F Group D ‘P’ Value 
No. of Cases 30 30 
0.78 
 
OVP 13 11 
AUB 12 12 
FU 5 7 
Table No:-6 DISTRIBUTION OF PROCEEDURE IN BOTH GROUPS 
PARAMETERS Group F Group D ‘P’ Value 
No. of Cases 30 30 
0.79 
 
VH PFR 12 11 
VH 18 19 
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ONSET OF SENSORY BLOCK T10 LEVEL 
The time taken to achieve a sensory level of T10 from the time of SAB was 
tested by alcohol swab [loss of cold sensation]. The mean time taken in Group F 
was 2.83±0.53min and in Group D was 2.67±0.47 min. There was statistically 
no significant difference among two groups [p < 0.207] Table No:-7 
Table No:-7 DISTRIBUTION OF MEAN ONSET OF SENSORY BLOCK 
[T10] IN MINS BY GROUPS 
PARAMETERS Group F Group D ‘P’ Value 
No. of Cases 30 30 
0.207 
 
MEAN 2.83 2.67 
S.D .531 .479 
Table No:-8 DISTRIBUTION O MEAN ONSET OF SENSORY BLOCK 
[T6] IN MINS BY GROUPS 
PARAMETERS Group F Group D ‘P’ Value 
No. of Cases 30 30 
0.207 
 
MEAN 4.80 4.77 
S.D 0.761 0.679 
53 
 
 
 
To reach Sensory block T6 level 
The time taken to achieve a peak sensory level of T6 from the time of 
SAB was tested by alcohol swab. The mean time taken in Group F was 4.80 ± 
0.76 min and in Group D was 4.77 ± 0.68 min. There was no statistically 
significant difference among two groups p < 0.207 [Table No:-8] 
Time to reach Bromage 3 motor block 
The time taken to achieve Bromage 3 from the time of SAB was tested 
by modified Bromage scale.  The mean time taken in Group F was 6.63 ± 0.69 
min. There was statistically no significant difference among two groups p < 
0.623 [Table No:-9] 
Table No:-9 DISTRIBUTION OF MEAN TIME TO REACH MOTOR 
BLOCK [Bromage 3] min by groups 
PARAMETERS Group F Group D ‘P’ Value 
No. of Cases 30 30 
0.623 
 
MEAN 6.63 6.53 
S.D 0.556 0.681 
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Duration of Sensory block 
The mean time taken for return of cold sensation to S1 level was 
358.97±46.73 min in Group F and in Group D was 459.03 ±56.9 mins. There 
was statistically significant difference among two groups in the duration of 
sensory block p < 0.000 Table No:-10 
Table No:-10 DISTRIBUTION OF MEAN TIME FOR REGRESSION OF 
SENSORY BLOCK [S1] IN MINS by groups 
PARAMETERS Group F Group D ‘P’ Value 
No. of Cases 30 30 
0.000** 
 
MEAN 358.97 459.03 
S.D 46.737 56.927 
Table No:-11 DISTRIBUTION OF MEAN TIME FOR REGRESSION OF 
MOTOR BLOCKADE [BROMAGE 0] IN MINS by groups 
PARAMETERS Group F Group D ‘P’ Value 
No. of Cases 30 30 
0.000** 
 
MEAN 231.83 288.63 
S.D 39.958 31.127 
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Duration of motor block 
The mean duration of return of motor block to Bromage scale zero [0] 
was 231.83±39.96 min in Group F and in Group D was 288.63±31.13 mins. 
There was statistically significant difference among two groups in the mean 
duration of motor block p < 0.000 [Table No:-11] 
Duration of time for Rescue analgesia 
The mean time for demand analgesia [defined as the time at which 
patient demands some mode of pain relief] was 212.67±38.97 mins in Group F 
and in Group D was 276.73±49.32 mins. There was statistically significant 
difference among two groups in the duration of time for demand analgesia p < 
0.000 [Table No:-12] 
No:-12 DISTRIBUTION OF MEAN TIME FOR RESCUE ANALGESIA 
IN MINS BY GROUPS 
PARAMETERS Group F Group D ‘P’ Value 
No. of Cases 30 30 
.000** 
 
MEAN 212.67 276.73 
S.D 38.976 49.321 
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Maximum grade of motor block 
The maximum degree of motor block in both groups was Grade 3. There 
was no statistically significant difference among two groups in the maximum 
Grade of motor block p < 1 Table No:-13 
Table No:-13 MAXIMUM GRADE OF MOTOR BLOCK by groups 
PARAMETERS Group F Group D ‘P’ Value 
 No % No % 
1 
 
No. of Cases 30  30  
Grade 3 30 100% 30 100%
Grade 2 0 0 0 0 
 Table No:-14 MAXIMUM LEVEL OF SENSORY BLOCK by [T4-
T6] groups 
PARAMETERS Group F Group D ‘P’ Value 
 No % No % 
0.086 
 
No. of Cases 30  30  
T4 4 13.3% 3 10.%
T6 26 86.6% 27 90.%
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Maximum level of Sensory Block [T4-T6]:- 
The range of maximum level of sensory block was T4-T6 in both groups. 
The median of the onset of sensory block was T6 in both groups. T4 was 13.3% 
in Group F and 10% in Group D. T6 was 86.6% in Group F and 90% in Group 
D which was statistically not significant < 1 Table No:-14 
Quality of surgical Anaesthesia 
Quality of surgical anaesthesia was excellent in all patients. There was no 
statistically significant difference among two groups p < 1 [Table No:15] 
Table No:-15 DISTRIBUTION OF CASES BY GROUPS AND QUALITY 
OF SURGICAL ANAESTHESIA 
PARAMETERS Group F Group D ‘P’ Value 
 No % No % 
1 
 
No. of Cases 30  30  
Excellent 30 100% 30 100%
Good 0 0 0 0 
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Side effects and complications 
The incidence of Hypotension in Group F was 30% and in Group D was 
10% which was significant statistically p < 0.05 [Table No:-16] 
Table No:-16 DISTRIBUTION OF CASES by Hypotension in Both groups 
PARAMETERS Group F Group D ‘P’ Value 
 No % No %  
0.83 
 
No. of Cases 30  30  
Hypotension 9 30% 6 20%
Table No:-17 DISTRIBUTION OF CASES by Groups and side effects 
Side effects Group F Group D ‘P’ Value 
 No % No % 0.301 
0.002** 
0.554 
1 
BRADYCARDIA 1/30 3.33% 3/30 10% 
PRURITIUS 8/30 26.66% 0 0% 
Vomiting 2 6.66% 1 3.33% 
INTRA OP 
ANALGESIA 
0 0% 0 0% 
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The incidence of Bradycardia in Group F was 3.33% and in group D was 
10% and there was statistically no significant difference in both groups p < 0.30 
Table No:-17 
The incidence of pruritus in Group F was 26.66% and in Group D no 
case of pruritus was observed p < 0.002 Table No:-17. 
The incidence of vomiting in Group F 6.66% & Group D 3.33% which 
was statistically not significant p < 0.55 Table No:-17 
The incidence of sedation score 2 was 100% in both the groups was 
statistically not significant p<1 Table No:-18 
Table No:-18 DISTRIBUTION OF CASES by sedation score 
PARAMETERS Group F Group D  P Value 
SEDATION 
SCORE 2 
No % No % 
1 
 
30/30 100% 30/30 100%
SEDATION 
SCORE 3 
0 0 0 0 
SEDATION 
SCORE 1 
0 0 0 0 
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DISCUSSION 
Subarachnoid Block is a commonly used anaesthetic technique for lower 
abdominal surgeries. There has been a growing interest in the use of analgesic 
additives to spinal local anaesthetics Alpha2 agonist like Dexmedetomidine 
have been shown to prolong the duration of both sensory and motor blockade 
and to provide extended postop analgesia. 
In this study 5μg of Dexmedetomidine was added to 13mg [2.8ml] of 
0.5% Hyperbaric Bupivacaine or 25μg of fentanyl added to 13mg [2.8ml] of 
0.5% Hyperbaric Bupivacaine and its efficacy as an adjuvant to subarachanoid 
Bupivacaine was studied in 60 patients undergoing elective Vaginal 
Hysterectomy and tension wall repair surgeries. 
ONSET OF SENSORY BLOCK 
The mean time to onset of sensory Block (T10 level) was 2.83 ± 0.53 
mins in Group F and 2.67 ± 0.48 mins in Group D. In our study the addition of 
5μg of Dexmedetomedine to Hyperbaric Bupivacaine did not shorten the onset 
of sensory block [T10 level] when compared to the addition of 25μg of fentanyl 
to Hyperbaric Bupivacaine. The onset of sensory block [T10 level] was similar 
in both groups. 
61 
 
 
 
This correlated with the study subhi M Al-Ghanem et al. who compared 
the effect of 5μg Dexmedetomidine Vs fentanyl 25μg in intra operative 
analgesia and the duration of sensory & motor block when added to 10mg 
intrathecal plain Bupivacaine and observed that there is no statistically 
significant difference between the two groups as regards to the onset time of 
sensory block at T10 level. 
Ibrahim F.a. Khalifa et al did a comparative study of adding intrathecal 
5μg Dexmedetomedine and 5μg of sufentanyl to 10mg of heavy Bupivacaine 
found that there is no statistically significant difference in the onset of sensory 
block T10 level Group D = 5.5±3.7, where Group 57 = 6.2±1.3 p < 0.69. 
Maximum level of sensory Block 
The median of the upper limit block was T6 in Group D and Group F. 
There was no statistically significant difference among the two groups in the 
maximum level of sensory Block. The addition of Dexmedetomidine to 
hyperbaric Bupivacaine did not increase the speed of sensory level when 
compared with 25μg  of fentanyl to hyperbaric Bupivacaine. 
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• Kanazi et al found that there is statistically no significant difference for 
the maximal sensory Block for 12mg Bupivacaine 0.5% alone or 
combined 3μg of Dexmedetomidine or 30μg of clonidine [p = 0.3]. 
• Mahmoud M. Al Mustafa et al found that addition of intrathecal 
Dexmedetomidine in increasing doses 5μg, 10mg of Dexmedetomidine 
with 12.5mg of Spinal Bupivacaine increased the level of sensory block 
as the dose of Dexmedetomidine increases. 
• Ibrahim F.A. Khalifa et al found that there is statistically no significant 
difference for the maximal sensory block when compared with 5μg of 
Dexmedetomedine and 5μg of sufentanyl to 10mg of heavy Bupivacaine 
Time to reach peak sensory Block (T6 level] 
The mean time to reach T6 level was 4.80 ± 0.76 mins in Group F and 
4.77 ± 0.68 mins in Group D. There is no statistically significant difference 
among the two groups. 
This correlated with the study subhi M. Al Ghanem et al who found that 
addition of 5μg of Dexmedetomidine and 25μg of fentanyl with 10mg of 
isobaric Bupivacaine intrathecally had no significant difference on the mean 
time to reach peak sensory level 19.34 ± 2.87 in Group D and 18.39 ± 2.46 in 
Group F p = 0.12. 
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Onset of Motor Block 
The mean time to achieve Bromage 3 score was 6.63 ± 0.56 mins an 
Group F and 6.53 ± 0.68 mins in Group D. The addition of 25μg fentanyl or 
5μg Dexmedetomidine to 13mg of Bupivacaine have no effect on the onset of 
motor block. 
This Correlated with the Study of 
Ibrahim F. A. Khalifa et al found that there is statistically no significant 
difference with 5μg of Dexmedetomidine and 5μg of sufentanyl to 10mg of 
heavy Bupivacaine on the mean time to achieve bromage 3 score. 
 Duration of Sensory Block 
In our study the duration of sensory block was 358.97 ± 46.74 mins in Group F 
and 459.03 ± 56.93 mins. The addition of 5μg of Dexmedetomidine to 
Hyperbaric Bupivacaine significantly prolonged the duration of sensory block. 
[Intrathecal Dexmedetomidine when combined with spinal Bupivacaine 
prolongs the sensory block by depressing the release of c-fibres transmitters and 
by hyperolarization of post-synaptic dorsal horn neurons]. 
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This correlated with the study 
• Subhi M. Al-Ghanem et al found that the addition of 5μg of 
Dexmedetomidine to 10mg of isobaric Bupivacaine 274.83 ± 73.4 
significantly prolong the duration of sensory blockade while 25μg of 
fentanyl to 10mg of isobaric Bupivacaine was 179.5±47.4. There was 
statistically significant difference among the two groups p < 0.00 
[Intrathecal Dexmedetomidine when combined with spinal Bupivacaine 
prolongs the sensory block by depressing the release of c-fibers 
transmitters and by hyperpolarization of post-synaptic dorsal horn 
neurons]. 
• Kanazi et al found that the addition of 3μg of Dexmedetomidine to 12mg 
of intrathecal Bupivacaine or 30μg of clonidine significantly prolonged 
the sensory block. 
• Al Mustafa MM et al studied that there is a significant difference in the 
duration of sensory block among three groups who received spinal 
Bupivacaine 12.5mg alone or combined with 5μg of Dexmedetomidine 
or with 10μg of Dexmedetomidine. He concluded that Dexmedetomidine 
has a dose dependent effect on the onset and regression of sensory and 
motor block when used in SAB. 
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DURATION OF MOTOR BLOCK 
In our study the mean duration of motor block was 231.83 ± 39.96 mins 
in Group F and 288.63 ± 31.13 mins in Group D. The addition of 5μg of 
Dexmedetomidine to 0.5% Bupivacaine significantly prolonged the duration of 
motor block. 
• Subi M. Al-Ghanem et al found in their study that 5μg of 
Dexmedetomidine to 0.5% hyperbaric Bupivacaine prolonged effect of 
motor blockade that 25μg of fentanyl to 0.5% hyperbaric Bupivacaine 
intrathecally. 
• Kanazi et al observed that addition of 12mg of Bupivacaine 
supplemented with dexmedetomidine and 12mg of Bupivacaine with 
30μg of clonidine intrathecally produces similar prolongation in the 
duration of motor block when compared 12mg of Bupivacaine alone. 
[The prolongation of motor block produced by subarachnoid Hyperbaric 
Bupivacaine combined with 5μg of Dexmedetomidine results from 
binding these agonist to motor neurons in the dorsal horn of the spinal 
cord]. 
• Mahmoud M. Al Mustafa et al found that Dexmedetomidine has a dose 
dependent effect on the duration of motor blockade when added to 
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• Ibrahim F.A Khalifa et al found that the addition of 5μg of 
Dexmedetomidine to 2ml of heavy Bupivacaine and 5μg of sufentanyl to 
2ml of heavy bupieracaine produces a significant difference in the 
duration of motor blockade. 
Quality of Surgical anaesthesia 
The quality of surgical anaesthesia was excellent in both groups. 
Though studies have shown 
• Ibrahim F.A. Khalifa et al found that the quality of surgical anaesthesia 
was better in patients received 5μg sufentanyl to 2ml of heavy 
Bupivacaine when compared to 5μg of Dexmedetomidine to 2ml of 
heavy Bupivacaine 
DURATION OF ANALGESIA 
In our study the mean time for Rescue analgesia is 212.67 ± 38.98 mins 
in Group F and 276.73 ± 49.321 [p < 0.000] which was statistically significant 
difference in the duration of Analgesia by two groups 
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Though studies have shown 
Ibrahim F.A. Khalifa et al found that the addition of 5μg of 
Dexmedetomidine to 10mg of Hyperbaric Bupivacaine and 5μg of sufentanyl to 
10mg of Hyperbaric Bupivacaine intrathecally produces no significant 
difference in the duration of pain relief Group SF = 265.8 ± 112.3, Group D = 
240. 2±77.3 mins [p < 08]. 
Complications 
In our study the incidence of Hypotension was 30% in Group F and 20% 
in Group D. Hypotension was mild to moderate in both groups which was not 
statistically significant different p < 0.083. The most significant side effects 
reported about the use of intrathecal α2 adrenoreceptor agonists are Bradycardia 
and hypotension. But in present study these side effects were not significant 
because small dose of intrathecal Dexmedetomidine was used. 
This correlated with the study 
• Kanazi et al studied that the addition of Dexmedetomidine or clonidine to 
Bupivacaine did not cause a significant decrease in the Blood pressure 
intraoperatively or postoperatively. Intrathecal local anaesthetics block 
the sympathetic outflow and reduce the blood pressure. The sympathetic 
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block is usually near-maximal with the doses used for spinal anaesthesia. 
The addition of a low dose of α2 agonist to a high dose of local 
anaesthetics does not further affect the near maximal sympatholysis. 
• Ibrahim F.A. Khalifa et al found that the addition of 5μg of 
Dexmedetomidine to spinal Bupivacaine and 5μg of sufentanyl to spinal 
Bupivacaine did not produce a significant difference in the incidence of 
hypotension. 
• Subi M. Al-Ghanem found that hypotension was more in fentanyl group 
than in the Dexmedetomidine group but it did not reach a significant 
difference. Mean while, hypotension occurred 25-30 minutes after spinal 
injection in 2 patients in the Dexmedetomidine group and one patient in 
fentanyl group had mild episodes of Hypotension in PACU. 
The incidence of brady cardia was 10% in Group D and 3.33% in Group F 
[p < 0.301]. There is no statistically significant difference among two groups 
• Ibrahim F.A. Khalifa et al found that there is statistically no significantly 
difference in the incidence of Bradycardia in both the groups with 5μg of 
sufentanyl to 10mg of 0.5% Bupivacaine and 5μg of Dexmedetomidine 
to 10mg of 0.5% Bupivacaine. 
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• Subi-M-Al-Ghanem et al found that there is statistically no significant 
difference in the incidence of Brady cardia among two groups of 5μg of 
Dexmedetomidine to 10mg of isobaric Bupivacaine and 25μg of fentanyl 
to 10mg of isobaric Bupivacaine intrathecally. 
The incidence of pruritus was 26.67% in Group F and 0% in Group D. There 
is statistically significant difference among two groups. 
This correlates with the study 
• Ibrahim F.A. Khalifa et al found that there is significant difference in the 
incidence of pruritus in the sufentanyl group. 
• Subi M. Al. Ghanem found that there is statistically significant difference 
in the incidence of pruritus. Pruritus after intrathecal fentanyl is reported 
to be 40-70% but if was only 13% in present study which can be 
explained by the fact that pruritus is a benign subjective symptom which 
is under reporting and usually needs to treatment 
• Bogra J. Srivastara P et al found there is statistically significant 
difference in the incidence of pruritus with 10mg of fentanyl, 12.5mg of 
fentanyl, added to hyperbaric Bupivacaine. 
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The incidence of vomiting, sedation, was not statistically significant in both 
the groups. 
This correlated with the study 
• Kanazi et al found that intrathecally administrated α2 agonist have a 
dose-dependent sedative effect (36,37). The doses of clonidine and 
dexmedotomedine selected in their study were at the lower end of the 
dosing spectrum. This explains the lack of sedative effects between the 
study groups B and C and the intraoperative anxiety one patient in Group 
D. 
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SUMMARY 
This double blinded prospective randomized controlled trial was 
designed to evaluate the onset and duration of sensory and motor block as well 
as operative analgesia and adverse effects of Dexmedetomidine vs fentanyl 
given intrathecally with heavy 0.5% Bupivacaine for spinal anaesthesia in 
patients scheduled for vaginal hysterectomy, vaginal wall repair patients 
receiving 25μg of fentanyl with 2.8cc of Bupivacaine intrathecally served as the 
control. 
The Following observations were made: 
• The addition of Dexmedetomidine significantly prolonged the duration of 
sensory and motor block. 
• The addition of Dexmedetomidine significantly prolonged the time for 
demand analgesia. 
• The addition of Dexmedetomidine intrathecally had no effect on the 
onset of sensory or motor block when compared with fentanyl. 
• The incidence of side effects was limited to the occurence of 
Hypotension, Bradycardia vomiting in the groups that received 
Dexmedetomidine intrathecally. 
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• The incidence of pruritus were more in the groups that received fentanyl 
intrathecally. 
• The addition of Dexmedetomidine intrathecally had similar effect on 
sedation when compared to fentanyl. 
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Conclusion 
Intrahtecal Dexmedetomidine supplementation of spinal block seems to 
be a good alternative to intrathecal fentanyl since it produces prolonged sensory 
block and motor block. It is evident that this type of block may be more suitable 
for lower abdomen and lower extremities surgeries. 
 A drawback of Dexmedetomidine supplemented spinal block 
characteristics is the increase in the duration of motor block which may not suit 
short term surgical procedures or ambulatory surgery. 
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PROFORMA 
 
Name:     Age:   IP No:   Date: 
Diagnosis:       Procedure: 
Preop assessment: 
H/O Medical illness: 
H/O Previous surgery: 
GENERAL EXAMINATION 
Height:   Weight: 
PR:    BP:    RR: 
CVS:    RS:    CNS: 
SPINE: 
AIRWAY: 
 
INVESTIGATIONS 
Hb:   BT:   CT:  BLOOD GROUPING & TYPING 
BLOOD SUGAR:    UREA:   CREATININE: 
ECG:     CXR: 
 
ASA 
Preloading  
 
SAB: 
Space Needle Size Approach Position Drug 
      
 
SENSORY BLOCK : 
Time to reach sensory block — T10 level [in mins] 
Time to reach peak sensory block : 
level  
time  
 
Time to regress to S1 dermatomal level [in mins] 
MOTOR BLOCK : MODIFIED BROMAGE SCALE 
Time to reach motor block [Bromage 3] 
Time to regress [Bromage 0] : 
Bromage 0 – able to move hip, knee and ankle 
Bromage 1 – able to move knee and ankle 
Bromage 2 – able to move ankle only 
Bromage 3 – unable to move 
TIME PR SBP DBP MAP SpO2 RR SIDE EFFECTS RSS 
BASE LINE         
5 min         
10 min         
15 min         
20 min         
25 min         
30 min         
35 min         
40 min         
45 min         
50 min         
55 min         
60 min         
65 min         
70 min         
75 min         
80 min         
85 min         
90 min         
95 min         
100 min         
 
Duration of surgery [in mins]: 
Side effects : 
Side effects Group 
Nausea/vomiting  
Puritus  
Hypotension  
Bradycardia  
Need for intraop analgesia  
 
Intraop events : 
IV fluids : 
Inj. Ephedrine [6 mg IV bolus] : 
Inj. Atropine [0.6 mg IV bolus] : 
Conversion to GA : 
QUALITY OF SURGICAL ANAESTHESIA : 
Excellent Good Poor 
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Pain score : [Verbal Rating Scale] 
 0 – no pain 
 1 – mild pain 
 2 – moderate pain 
 3 – severe pain 
RAMSEY SEDATION SCORE : 
1 – anxious and agitated or restless or both 
2 – co-operative, oriented and calm 
3 – responsive to commands only 
4 – exhibiting brisk response to light glabellar tap or loud auditory stimulus 
5 - exhibiting sluggish response to light glabellar tap or loud auditory stimulus 
6 – unresponsive 
 
POSTOP ANALGESIC CONSUPTION : 
Time of first rescue analgesic : 

Distribution of Mean Age, Height & Weight by Groups 
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Distribution of Mean ONSET of Sensory Blocks T10 in Mins by Groups 
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Distribution of Mean ONSET of Sensory Blocks T6 in Mins by Groups 
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Distribution of Mean Time to Reach Motor Block B3 in Mins by Groups 
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Distribution of Mean Time for Regression of Sensory Block [S1] Mins by Groups 
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Distribution of Mean Time for Regression of Motor Block [B0] Mins by Groups 
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Distribution of Mean Time for Rescue Analgesia  Mins by Groups 
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Maximum Grade of Motor Block by Groups 
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Maximum Level of Sensory Block [T4-T6] by Groups 
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Distribution of Cases by Groups and Side Effects 
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Hypotension
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S.NO Age Diagnosis Procedure ASA Duration 
of 
surgery 
in mins 
Intra 
op 
Side 
Effects 
Drugs IOP 
ANAL
PSB MMB Con.to 
GA 
QSA SENSORY 
BLOCK IN 
MIN 
  
  MOTOR 
BLOCK in 
Mins 
 
RESCUE 
                          T10 T6 regress 
to S1 
PMB regress ANALG in 
MIN 
  Group BF 2.8 cc of 0.5% Bupivacaine + 25 µg Fentanyl 0.5 cc 
  
           
1 35 UVP VH/PFR 1 95 P   NIL T6 B3 NIL EXC. 3 5 386 7 240 300 
2 45 AUB VH 1 40 P/H EP 6 NIL T6 B3 NIL EXC. 3 5 379 7 186 220 
3 47 UVP VH/PFR 1 60 P/H/B EP6/A0.6 NIL T6 B3 NIL EXC. 3 6 340 7 322 225 
4 35 AUB VH 1 90 NIL   NIL T6 B3 NIL EXC. 3 6 392 7 243 240 
5 50 UVP VH/PFR 1 100 H EP 6 NIL T6 B3 NIL EXC. 3 5 394 7 277 210 
6 47 FU VH 1 65 H EP 12 NIL T4 B3 NIL EXC. 2 5 333 7 161 120 
7 50 UVP VH/PFR 1 40 P NIL NIL T6 B3 NIL EXC. 3 5 361 7 183 213 
8 55 UVP VH/PFR 1 90 NIL NIL NIL T6 B3 NIL EXC. 3 5 350 7 250 210 
9 40 AUB VH 1 85 NIL NIL NIL T6 B3 NIL EXC. 3 6 348 7 281 185 
10 55 UVP VH/PFR 1 60 V EM 4 NIL T6 B3 NIL EXC. 3 5 355 7 250 207 
11 39 FU VH 1 60 H EP 6 NIL T6 B3 NIL EXC. 4 6 330 8 240 210 
12 50 UVP VH/PFR 1 65 V/P/H EM4/EP6 NIL T6 B3 NIL EXC. 3 6 245 7 226 170 
13 40 AUB VH 1 75 NIL NIL NIL T4 B3 NIL EXC. 3 4 366 6 246 270 
14 37 AUB VH 1 50 NIL NIL NIL T6 B3 NIL EXC. 3 5 380 6 276 285 
15 38 UVP VH/PFR 1 60 NIL NIL NIL T6 B3 NIL EXC. 3 4 283 6 191 195 
16 56 FU VH 1 55 NIL NIL NIL T6 B3 NIL EXC. 4 4 405 6 196 240 
17 45 AUB VH 1 70 NIL NIL NIL T6 B3 NIL EXC. 3 4 365 7 295 180 
18 55 UVP VH/PFR 1 135 NIL NIL NIL T4 B3 NIL EXC. 2 4 517 6 301 285 
19 34 AUB VH 1 90 NIL NL NIL T6 B3 NIL EXC. 2 4 333 7 244 185 
20 40 AUB VH 1 40 NIL NIL NIL T6 B3 NIL EXC. 2 4 391 6 184 205 
21 50 UVP VH/PFR 1 100 H/P EP6 NIL T6 B3 NIL EXC. 3 4 390 6 211 240 
22 40 UVP VH/PFR 1 55 NIL NIL NIL T4 B3 NIL EXC. 3 5 366 6 219 240 
23 42 FU VH 1 55 NL NIL NIL T6 B3 NIL EXC. 3 5 371 7 178 180 
24 37 AUB VH 1 35 NIL NIL NIL T6 B3 NIL EXC. 3 6 350 7 240 190 
25 40 AUB VH 1 30 NIL NIL NIL T6 B3 NIL EXC. 2 4 368 6 230 200 
26 50 UVP VH 1 120 P/H/V EM4/EP6 NL T6 B3 NIL EXC. 2 4 365 6 190 185 
27 56 UVP VH/PFR 1 90 NIL NIL NIL T6 B3 NL EXC. 2 4 366 6 195 180 
28 40 AUB VH 1 60 P/V/H EM4/EP6 NIL T6 B3 NL EXC. 3 5 290 7 220 240 
29 50 FU VH 1 70 NIL NL NIL T6 B3 NIL EXC. 3 4 350 6 240 195 
30 40 AUB VH 1 85 NIL NL NIL T6 B3 NIL EXC. 3 5 300 7 240 175 
 
INTRAOP VITALS MONITORING GROUP F 
  Time in Mins Heart Rate 
S.NO Basal 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 
1 109 109 101 98 98 98 96 97 99 100 95 91 83 86 86 89 91 80 86 86 83 84 84 86 83 83   
2 72 72 90 68 64 66 68 72 70 72 70 72 71 70 72 72 72 70 72          
3 68 68 64 60 62 62 49 48 70 72 68 64 66 68 64 68 66 64 62          
4 87 87 81 88 88 62 79 79 78 72 72 78 78 72 78 78 70 76 76 74 74 72 72 70 72    
5 86 86 88 86 84 84 84 88 86 78 78 78 78 76 80 80 80 78 78 78 80        
6 70 70 72 70 80 78 84 88 90 92 88 86 86                
7 80 80 78 74 73 74 72 68 68 68                   
8 64 64 63 62 63 63 58 59 59 59 62 60 60 56 58 58 58 55 56 57 57 56       
9 89 89 86 86 86 90 86 81 86 82 84 84 79 88 84 75 75 84 85 84 82 83 82 84 88    
10 83 83 82 90 79 71 68 66 62 66 68 60 64 112 64 66 66 68 64          
11 78 78 76 78 71 71 71 68 67 66 70 67 66 66               
12 77 77 73 71 80 74 76 79 80 77 77 77 79 79 78 86 86 87           
13 75 75 76 69 68 66 64 65 70 70 68 65 64 71 77 64 64 64           
14 110 110 95 86 84 94 77 73 75 71 72 72 72 73               
15 72 72 67 69 66 69 72 63 62 64 56 58 64 57 58              
16 96 96 94 89 79 80 83 81 80 73 72 69 68 77 72 72 70 72 72 70 78 76 74 78 80    
17 96 96 98 98 99 98 98 97 96 97 98 99 110 112 110 99 98            
18 108 108 92 88 84 84 83 81 82 82 72 73 73 74 72 73 63 62 69 62 62 68 68 72 88 86 84 83 
19 107 107 107 106 103 97 85 77 81 86 90 86 87 86 82 82 84 82 86 87 81 81 86      
20 68 68 68 66 64 60 68 62 65 64 64 62 61 60 62              
21 69 69 74 76 71 61 64 68 79 81 80 84 69 88 80 91 92 92 90 88 84 84 82 81     
22 82 82 86 84 83 82 80 78 76 74 68 68 70 72 74 78 87            
23 80 80 82 80 82 80 78 76 74 72 68 67 64 64               
24 108 108 106 98 96 94 98 98 96 98 96 1  00                 
25 86 86 84 86 82 88 86 82 78 76 76 74                 
26 86 86 84 82 81 80 78 78 79 76 74 73 72 71 70 68 68 70 70          
27 78 78 76 74 71 70 72 70 68 68 68 66 68                
28 90 90 90 90 90 89 88 87 84 86 86 88 80 81 80              
29 80 80 78 77 75 74 72 71 70 72 74 72 70 68 68 70 75 74           
30 76 76 77 74 78 76 78 76 75 74 72 70 68 70 72 74 75            
 
  Time in Mins  Blood Pressure 
S.NO Basal 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 
1 144/97 144/97 123/74 122/78 118/74 129/84 113/89 114/72 113/73 112/73 112/77 111/75 111/75 112/75 112/57 99/72 104/64 100/64 105/65 101/67 103/70 110/80 101/67 110/70 110/70 120/70   
2 135/87 135/87 101/56 102/51 89/47 106/61 98/56 114/68 111/70 106/62 104/64 106/62 104/63 104/60 106/63 108/60 111/70 110/78 118/80          
3 110/70 110/70 90/60 90/60 80/60 80/60 90/70 90/60 85/60 97/58 91/63 97/63 87/53 87/43 98/60 98/60 88/50 88/50 98/70 98/63         
4 120/70 120/70 120/75 123/67 116/62 118/72 110/72 109/68 97/65 100/65 100/66 97/57 97/63 94/58 88/58 113/69 102/62 108/68 112/57 107/59 120/64 126/76 133/80 133/80 128/80    
5 121/84 121/84 132/85 125/80 112/73 110/68 117/66 118/79 118/79 128/76 118/81 117/68 106/69 106/69 116/76 117/66 117/66 118/79 128/96 117/68 116/76        
6 110/80 110/80 100/80 100/70 90/60 100/70 100/70 80/60 100/70 80/70 96/70 90/70 100/72                
7 130/90 130/90 135/78 137/74 140/90 151/96 145/70 149/78 140/90 137/74                   
8 110/70 110/70 110/80 130/80 110/70 111/65 110/67 122/68 113/65 115/67 112/71 113/69 111/71 110/65 116/64 106/65 106/65 106/65 104/67 104/67 105/64        
9 120/80 120/80 117/84 120/69 117/74 107/64 111/64 108/66 111/63 109/61 105/57 102/58 106/66 110/64 108/68 114/66 109/69 108/68 112/71 118/70 120/74 108/68 110/70 111/63 108/66    
10 153/82 153/82 133/82 132/78 122/69 112/68 108/64 113/64 107/64 105/58 104/61 105/64 102/62 106/56 99/59 107/58 109/60 103/60 104/62          
11 111/76 111/76 108/73 105/76 101/69 103/67 102/72 97/62 99/68 99/63 94/61 97/59 91/58 88/49 106/68              
12 114/89 114/89 98/68 83/54 104/72 101/70 103/73 90/62 108/70 97/63 92/66 93/58 97/58 89/65 115/82 110/79 113/81 104/79           
13 156/96 156/96 160/90 140/90 142/81 150/80 130/85 120/79 112/79 112/80 111/70 114/78 110/70 118/72 112/70 100/71 89/63 98/62           
14 133/83 133/83 133/83 120/68 117/62 112/64 111/64 110/55 113/78 109/56 112/60 114/63 111/59 108/59 108/59              
15 114/69 114/69 116/74 108/74 120/79 105/67 101/66 99/60 91/64 98/64 98/59 95/62 99/68 102/67 99/67 111/74 123/82 114/84 111/77 106/74 106/74 117/81 111/77 106/74 106/74    
16 145/94 145/94 150/90 126/80 133/98 130/93 112/86 112/82 126/88 123/82 114/84 111/77 106/74 106/74 106/74 119/89 113/70            
17 122/86 122/86 122/88 124/75 126/80 124/79 112/80 122/77 115/74 116/76 107/73 113/69 113/70 121/78 121/78 113/70 112/64 116/72 116/72 102/68 102/68 100/70 109/70 118/69 117/57 100/67 109/60 102/68
18 146/80 146/80 145/95 146/90 141/97 130/90 128/92 125/69 109/64 112/64 118/69 117/57 116/67 109/60 109/60 100/70 102/73 102/73 102/73 102/73 111/71 120/82 120/80      
19 124/84 124/84 137/90 128/71 98/54 95/54 98/58 99/68 105/65 103/67 106/65 112/69 110/68 118/78 118/78 112/73             
20 120/80 120/80 110/80 110/80 120/80 110/70 107/60 110/70 110/80 110/70 100/60 110/70 108/68 110/70 110/70              
21 155/82 155/82 115/69 104/68 104/60 97/56 96/55 80/57 108/54 88/54 98/55 108/61 93/60 96/56 87/43 85/44 99/69 110/80 114/75 114/70         
22 140/80 140/80 150/80 115/72 121/77 121/77 111/77 114/75 114/75 119/76 117/76 110/77 116/70 116/77 110/70 110/70 110/70            
23 130/80 130/80 140/80 128/87 127/73 121/70 119/76 119/73 119/73 112/60 117/67 113/67 110/70 117/67               
24 150/80 150/80 150/80 140/80 139/88 129/85 118/78 106/70 106/70 110/72 110/72                  
25 120/76 120/76 113/69 124/82 113/62 100/70 97/85 113/69 113/69 120/80 113/62                  
26 130/80 130/80 120/78 110/78 110/70 110/68 110/68 110/70 120/80 110/72 100/68 100/68 110/70 110/68 120/80 110/78 110/68 110/70 110/68          
27 133/83 133/83 130/80 110/78 120/80 118/78 120/78 118/78 110/68 106/61 88/60 110/76 120/80                
28 120/80 120/80 130/80 118/78 117/64 107/64 110/70 113/65 110/68 100/65 100/65 110/70 118/75 120/70 118/75              
29 120/70 120/70 120/75 123/67 116/62 118/72 110/68 118/72 112/73 112/77 117/75 111/75 111/70 108/68 110/70 118/78 120/80 120/80           
30 110/70 110/70 117/84 117/74 107/64 111/65 111/64 113/65 115/67 112/71 113/69 111/71 110/70 108/68 110/70 118/78             
 
 Time in Mins    RSS 
S No. 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 
1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2   
2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
4 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2    
5 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2        
6 2 2 2 2 2 2 2 2 2 2 2 2                
7 2 2 2 2 2 2 2 2 2                   
8 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2       
9 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2    
10 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
11 2 2 2 2 2 2 2 2 2 2 2 2 2               
12 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2           
13 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2           
14 2 2 2 2 2 2 2 2 2 2 2 2 2               
15 2 2 2 2 2 2 2 2 2 2 2 2 2 2              
16 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2    
17 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2            
18 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
19 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2      
20 2 2 2 2 2 2 2 2 2 2 2 2 2 2              
21 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2     
22 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2            
23 2 2 2 2 2 2 2 2 2 2 2 2 2               
24 2 2 2 2 2 2 2 2 2 2 2                 
25 2 2 2 2 2 2 2 2 2 2 2                 
26 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
27 2 2 2 2 2 2 2 2 2 2 2 2                
28 2 2 2 2 2 2 2 2 2 2 2 2 2 2              
29 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2           
30 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2            
 
 Time in Mins   SPO2 
S.NO 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 
1 99% 99% 99% 99% 99% 99% 99% 98% 99% 99% 97% 98% 98% 98% 98% 99% 98% 98% 98% 98% 98% 98% 98% 98% 99%   
2 99% 99% 99% 98% 99% 98% 99% 99% 99% 99% 97% 98% 98% 98% 99% 99% 99% 99%          
3 99% 99% 99% 98% 98% 98% 99% 99% 99% 99% 97% 98% 99% 99% 99% 99% 99% 99%          
4 100% 100% 100% 99% 99% 99% 99% 99% 99% 99% 97% 99% 99% 99% 99% 99% 99% 99% 98% 99% 99% 98% 99% 99%    
5 99% 99% 99% 99% 98% 99% 98% 98% 99% 99% 98% 99% 98% 97% 97% 98% 98% 98% 98% 98%        
6 99% 98% 98% 99% 98% 98% 99% 99% 99% 98% 98% 98%                
7 97% 97% 97% 100% 98% 98% 100% 99% 99%                   
8 98% 98% 98% 99% 99% 99% 99% 99% 100% 98% 99% 98% 98% 98% 98% 98% 98% 98% 98% 99% 99%       
9 99% 99% 99% 99% 99% 100% 99% 98% 98% 99% 99% 99% 98% 98% 98% 97% 97% 97% 99% 99% 98% 98% 98% 98%    
10 99% 98% 98% 98% 98% 99% 98% 98% 99% 98% 98% 99% 98% 98% 98% 98% 99% 99%          
11 98% 99% 99% 99% 99% 99% 99% 99% 99% 97% 98% 98% 98%               
12 100% 100% 100% 100% 99% 98% 99% 99% 98% 99% 98% 99% 98% 98% 99% 98% 98%           
13 100% 100% 100% 99% 99% 99% 98% 99% 98% 98% 99% 99% 98% 98% 98% 98% 98%           
14 99% 99% 99% 100% 98% 99% 99% 97% 99% 98% 99% 98% 99%               
15 98% 98% 98% 99% 99% 98% 100% 97% 98% 99% 99% 98% 99% 99%              
16 99% 99% 99% 99% 99% 98% 100% 99% 99% 98% 99% 99% 99% 98% 98% 98% 98% 99% 99% 98% 98% 98% 98% 99%    
17 100% 100% 100% 98% 98% 99% 99% 98% 98% 98% 100% 99% 99% 99% 98% 98%            
18 99% 99% 99% 99% 99% 99% 99% 99% 99% 98% 100% 99% 99% 97% 97% 97% 98% 98% 98% 99% 99% 99% 99% 99% 99% 98% 99% 
19 98% 98% 98% 99% 99% 100% 98% 98% 99% 99% 99% 98% 99% 99% 98% 98% 98% 99% 99% 99% 98% 98%      
20 99% 99% 99% 99% 99% 99% 98% 98% 99% 99% 99% 98% 98% 98%              
21 98% 98% 98% 99% 98% 99% 98% 99% 99% 99% 98% 98% 99% 99% 99% 98% 98% 98% 98% 98% 98% 98%      
22 99% 99% 99% 985% 98% 99% 98% 99% 99% 99% 98% 98% 98% 97% 97% 97%            
23 100% 100% 100% 99% 99% 98% 99% 99% 99% 99% 99% 98% 99%               
24 99% 99% 99% 99% 100% 99% 99% 99% 99% 98% 98%                 
25 99% 99% 99% 98% 99% 98% 99% 99% 99% 98% 99%                 
26 98% 98% 98% 98% 98% 99% 99% 99% 99% 98% 99% 99% 98% 98% 98% 98% 98% 98%          
27 99% 99% 99% 98% 98% 99% 100% 100% 99% 98% 99% 97%                
28 99% 99% 99% 98% 98% 98% 100% 100% 99% 99% 99% 97% 98% 98%              
29 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 98% 98% 98% 9  8% %99            
30 99% 99% 99% 99% 99% 99% 99% 99% 99% 98% 99% 99% 98% 98% 9  8% 8%9             
 
 Time in Mins  RR 
S.N0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 
1 16 16 14 14 14 14 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12   
2 14 14 14 14 14 14 12 12 12 12 12 12 12 12 12 12 12 12          
3 18 18 16 14 14 14 12 12 12 12 14 14 14 14 14 14 12 12          
4 14 14 14 14 16 14 12 12 12 12 12 12 14 14 12 12 12 12 14 14 12 12 12 14    
5 16 14 14 14 14 14 12 14 12 14 14 14 14 14 12 12 12 12 12 12        
6 18 16 14 14 14 14 14 14 12 12 12 12                
7 16 16 14 14 14 16 12 12 12                   
8 14 14 14 14 14 16 14 12 12 12 12 12 12 12 12 12 14 14 12 12 12       
9 16 16 16 14 14 14 14 12 12 12 12 12 12 12 12 14 14 14 14 12 12 12 12 12    
10 16 16 16 16 16 14 14 12 12 12 12 12 14 14 14 14 14 12          
11 16 16 16 14 14 16 14 12 12 12 12 12 12               
12 16 16 16 16 16 14 16 14 14 12 12 14 14 14 12 12 14           
13 16 16 16 16 16 14 14 14 14 12 12 12 12 12 12 12 12           
14 16 16 16 16 16 14 14 14 14 12 12 12 12               
15 14 14 14 14 14 16 14 14 14 12 12 12 12 12              
16 16 16 16 16 16 14 14 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12    
17 16 16 16 16 14 14 14 12 12 12 12 12 12 12 12 12            
18 16 16 16 16 16 14 14 14 12 14 14 14 14 14 14 14 16 16 16 16 16 14 14 14 14 14 14 
19 18 18 18 16 14 14 14 12 12 14 14 14 14 14 14 14 14 14 14 14 14 14      
20 16 16 16 14 14 14 14 12 12 12 12 12 12 12              
21 16 16 16 14 12 14 14 12 12 14 14 14 14 14 14 14 14 14 14 14 14 14 14     
22 14 14 14 12 12 14 14 12 12 12 12 12 12 12 12 12            
23 16 16 16 14 14 14 14 12 12 12 12 12 12               
24 16 16 16 14 14 14 14 12 12 12 12                 
25 16 16 16 14 14 14 14 12 12 12 12                 
26 16 16 16 14 14 14 12 12 12 14 14 14 14 14 14 14 14 14          
27 18 18 18 16 14 14 12 12 12 12 12 12                
28 16 16 16 16 14 14 12 12 12 12 12 12 12 12              
29 16 16 16 14 14 14 12 12 12 14 14 14 14 14 14 14 14           
30 18 18 18 16 14 14 12 12 12 14 12 12 12 12 12 12            
 
POST OP MONITORING GROUP F 
  Time in Mins  Heart Rate 
S.NO Basal 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 300 315 330 345 360 
1 84 84 84 83 82 90 88 86 84 98 98 100 96 96 94 93 88 86 84 84 82 80    
2 66 66 68 66 68 68 70 72 72 69 60 64 66 62 68 68 72 72 80 72 78 80    
3 70 70 68 70 72 68 70 72 76 78 80 72 78 78 80 82 80 82 82       
4 74 74 76 74 76 74 76 74 76 74 76 74 74 74 76 74 74 76 74 80 81 86    
5 86 86 88 84 84 84 88 86 84 84 84 84 86 84 84 86 86 84 84 86      
6 87 87 88 86 88 86 88 86 92 94 94 88 86 85 84 83 84 84 82       
7 70 70 72 72 74 70 70 72 72 74 74 74 70 72 72 74 70 68 70 72 70 72 70 72  
8 65 65 65 64 64 65 67 78 66 67 78 66 70 68 63 64          
9 81 81 74 74 68 70 68 49 45 42 60 64 61 62 64 65 61 62 64       
10 69 69 68 68 66 64 63 68 70 64 64 66 68 70 65 76 75 72 80       
11 70 70 70 68 70 68 68 71 69 70 68 69 70 70 70 70          
12 89 89 89 83 88 91 92 87 89 90 82 80 80             
13 68 68 64 68 64 68 64 64 68 64 68 64 68 64 64 64 72 72 72       
14 68 68 64 66 68 70 72 74 74 72 72 72 70 70 72 70 70 70 72 70      
15 72 72 70 72 72 72 70 70 70 72 70 72 70 72 70 70 72 72        
16 77 77 77 77 78 72 80 84 82 82 84 81 81 82 82 76 74 76 78       
17 110 110 112 110 112 106 108 104 100 100 98 96 98 92 96 98          
18 65 65 63 63 70 72 70 74 74 72 77 80 77 80 77 80 77 80 71 77 80 77 72 74 76 
19 84 84 82 80 81 80 82 82 82 82 80 80 80 80 82 82          
20 72 72 70 68 68 66 70 72 74 74 78 78 72 68 68 66 68 66 66 68 66 64 64   
21 70 70 72 70 70 70 68 68 70 72 68 60 72 78 60 71 70 72 72 70      
22 85 85 84 85 84 84 85 84 85 84 85 84 84 84 83 83 84 84 82 82 82 86 88   
23 80 80 82 82 80 88 84 86 88 84 86 88 82 84 78 76 78 78 74 80 82 82    
24 108 108 106 104 100 98 96 94 96 94 96 96 98 92 96 98 94 96 98 94 94 98    
25 88 88 90 92 90 94 95 92 93 94 95 92 90 90 92 88 88 90 91 88 86 88 86 90  
26 72 72 71 72 74 72 70 72 74 74 76 78 78 80 81 82 84 86 80 82      
27 70 70 68 70 72 68 70 72 72 74 76 74 74 76 76 76 78         
28 70 70 72 72 74 70 70 70 72 74 78 80 86 86 84 88 86 86 86 88      
29 84 84 83 83 82 90 88 86 84 98 100 96 96 94 93 93          
30 70 70 70 68 68 72 68 70 70 72 78 76 76 76 74 74          
 
  Time in Mins   Blood Pressure 
S.NO Basal 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 300 315 330 345 
1 110/70 110/70 103/70 100/64 100/64 104/64 112/67 112/67 113/74 112/72 110/70 110/70 105/68 101/67 105/64 103/70 103/70 100/70 110/80 120/80 120/80 120/80   
2 100/70 100/70 110/70 118/68 108/68 103/60 110/70 110/70 104/65 122/84 120/90 107/61 110/70 110/70 110/70 103/80 110/80 110/80 110/80 110/80 100/78 100/78   
3 110/70 110/70 100/60 100/60 104/64 100/60 98/62 110/70 110/72 110/80 110/70 110/80 1110/70 108/70 108/70 110/70 100/70 110/70 110/70      
4 110/60 110/60 100/68 110/70 110/70 100/68 100/60 90/60 92/62 110/70 110/70 108/60 108/68 110/70 110/70 100/68 100/68 110/70 110/70 100/68 110/70 110/70   
5 120/80 120/80 130/80 122/80 112/73 110/68 110/68 110/68 120/80 112/78 112/78 120/80 130/80 130/80 130/80 120/80 118/80 120/80 112/73 128/76     
6 120/80 120/80 120/87 120/80 110/80 110/80 120/80 120/80 110/80 130/80 130/80 140/90 130/80 120/70 120/80 120/80 110/70 110/70 120/80      
7 120/70 120/70 120/70 120/80 130/80 130/80 120/80 120/70 120/80 120/80 130/80 140/80 130/80 130/70 130/80 110/70 130/80 130/80 120/80 120/78 120/80 128/78 110/70 110/70
8 110/70 110/70 113/78 110/70 113/78 112/71 116/72 105/67 94/56 103/65 120/80 112/78 110/70 113/64 110/70 103/65         
9 131/90 131/90 135/89 135/89 144/80 142/90 143/93 135/95 150/80 154/44 145/90 150/90 151/90 137/93 135/90 150/90 140/90 140/90 150/90      
10 104/64 104/64 110/60 114/69 108/69 119/66 111/69 121/71 129/79 135/70 125/80 123/71 122/70 118/68 120/70 118/70 108/73 106/70 108/68      
11 104/64 104/64 110/60 114/69 108/69 119/66 111/69 121/71 129/79 135/70 125/80 123/71 122/70 118/68 120/70 118/70         
12 107/77 107/77 102/63 100/56 106/72 102/72 118/79 114/77 108/73 114/81 110/78 100/70 100/70            
13 90/60 90/60 110/60 120/70 110/60 100/60 100/60 90/60 100/60 100/60 100/60 110/70 110/70 100/70 100/70 100/70 100/80 110/90 100/80      
14 90/60 90/60 92/60 90/60 100/60 100/60 100/70 100/60 100/70 100/60 100/70 100/60 100/60 100/60 100/60 100/60 110/70 110/70 110/70      
15 110/60 110/60 100/60 110/60 100/60 100/60 110/60 100/60 100/60 100/60 100/60 110/70 110/70 120/80 120/80 110/70 110/70        
16 98/61 98/61 97/60 97/70 102/72 104/70 102/72 106/72 110/70 110/70 120/80 130/80 120/80 100/80 120/76 116/72 110/72 106/72 110/76 116/72     
17 110/80 110/80 112/80 110/80 112/70 110/70 106/72 106/70 106/74 100/70 102/76 102/70 110/76 120/76 120/76 126/74         
18 130/70 130/70 130/70 125/69 120/70 120/70 110/80 110/80 120/80 120/80 130/80 130/80 140/80 140/80 140/80 130/80 140/80 140/80 140/80 138/78 130/80 130/80 130/80 140/80
19 110/80 110/80 110/70 100/70 110/70 100/60 110/70 110/60 110/70 100/70 110/70 100/60 110/60 110/60 110/70          
20 100/60 100/60 98/60 110/60 107/67 103/60 110/68 110/70 110/70 120/80 127/78 118/80 116/72 110/76 100/60 110/70 110/70 108/68 110/70 120/80 120/80 110/78 110/78  
21 100/60 100/60 90/62 100/62 100/60 98/70 100/60 98/70 98/70 98/70 100/60 110/60 100/60 113/80 110/80 112/82 106/70 110/70 117/63 110/70     
22 140/80 140/80 130/80 140/80 130/78 130/70 140/70 150/70 150/80 140/70 150/70 114/70 150/70 150/70 151/83 130/80 130/80 130/80 120/80 110/70 130/80 130/80 130/80  
23 128/80 128/80 130/70 120/70 124/73 119/76 114/73 115/69 112/66 112/60 117/67 113/69 112/67 103/56 110/70 120/80 130/80 120/80 124/73 120/80 115/69 120/70   
24 108/78 108/78 120/80 110/70 120/80 110/80 120/80 130/80 130/80 140/80 120/80 120/80 120/80 130/80 130/80 140/80 140/80 130/80 130/80 140/80 140/80 140/80   
25 110/80 110/80 120/80 110/80 110/70 110/80 120/78 110/70 110/70 120/80 128/78 130/80 110/80 120/80 120/80 110/70 118/78 106/70 110/70 120/70 118/80 118/78 120/80 120/80
26 110/70 110/70 110/70 118/68 108/68 103/60 110/70 110/70 104/65 122/84 120/80 107/61 110/70 110/70 110/70 103/80 105/64        
27 110/60 110/60 100/68 110/70 110/70 110/70 103/60 110/70 104/65 122/84 110/70 107/61 103/80 103/80 110/70 120/80 110/80 110/80       
28 120/80 120/80 110/60 118/68 108/68 110/68 112/67 110/60 113/74 112/72 110/70 110/70 105/68 101/67 120/80 130/80 130/80 130/80 130/80 130/80     
29 110/80 110/80 120/80 118/68 118/68 110/68 112/67 110/80 110/70 110/70 100/60 110/60 110/76 120/80 110/78 120/80 120/80        
30 131/90 131/90 135/89 138/88 135/8- 140/90 141/92 140/90 140/90 138/90 130/90 138/90 130/90 130/90 130/90          
 
  Time in Mins   PAIN SCORE           
S.NO 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 300 315 330 345 360 
1 0 0 0 0 0 0 1 1 2 2 2 2 2 1 1 1 0 0 0 0 0    
2 0 0 0 0 0 0 0 0 1 1 1 2 2 2 2 2 1 1 1 1 1    
3 0 0 0 0 0 0 1 1 2 2 2 2 1 1 1 1 0 0       
4 0 0 0 1 1 1 1 2 2 2 2 2 1 1 1 1 1 1 1 0 0    
5 0 0 0 0 0 1 1 2 2 2 2 2 1 1 1 1 1 0 0      
6 0 0 0 0 0 0 0 1 2 2 2 2 2 2 1 1 0 0       
7 0 0 0 0 0 0 0 0 0 1 1 2 2 2 2 2 2 2 1 1 1 0 0  
8 0 0 0 0 1 1 2 2 3 3 2 2 2 0 0          
9 0 0 0 0 0 2 2 1 1 2 2 2 2 1 1 0 0        
10 0 0 0 0 0 0 0 2 2 2 2 3 3 2 2 1 0 0       
11 0 0 0 0 0 0 0 2 2 2 2 3 3 2 2          
12 0 0 0 0 1 2 1 1 2 0 0              
13 0 0 0 0 0 0 0 0 0 1 3 3 2 1 1 1 0 0       
14 0 0 0 0 0 1 2 2 1 1 1 1 1 0 0 0 0 0 0      
15 0 0 0 1 2 3 3 2 2 1 1 1 0 0 0 0         
16 0 0 0 1 1 1 2 2 2 2 2 1 1 1 1 0 0 0 0      
17 0 0 0 0 0 1 1 2 2 2 1 1 1 0 0          
18 0 0 0 0 0 0 0 0 0 1 1 1 2 2 2 1 1 1 1 0 0 0 0 0 
19 0 0 0 0 0 1 1 2 2 1 0 0 0            
20 0 0 0 0 0 0 1 2 2 2 2 2 1 1 1 1 1 0 0 0 0 0   
21 0 0 0 0 0 0 0 0 1 2 2 2 2 1 1 1 1 0 0 0 0    
22 0 0 0 0 0 0 0 0 1 1 2 2 2 2 2 1 1 1 1 0 0 0   
23 0 0 0 0 0 1 2 2 2 2 2 1 1 1 1 1 0 0 0 0 0    
24 0 0 0 0 0 0 1 1 2 2 2 2 2 1 1 1 1 1 0 0 0    
25 0 0 0 0 0 0 0 0 1 2 2 2 2 2 1 1 1 0 0 0 0    
26 0 0 0 0 0 0 1 1 2 2 2 2 2 1 1 1 1 0 0      
27 0 0 0 0 1 1 1 2 2 2 2 2 2 2 2 2 1 1 0 0     
28 0 0 0 0 1 1 1 2 2 2 2 2 2 1 1 1 1 1 0 0     
29 0 0 0 0 1 1 2 2 2 2 2 2 1 1 0 0 0        
30 0 0 0 0 1 1 2 2 2 2 2 2 1 1 0 0         
 Time in Mins  Ramsay Sedation Score            
S.N0 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 300 315 330 345 360 
1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2    
2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2    
3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2       
4 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2    
5 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2      
6 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2       
7 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2  
8 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
9 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2        
10 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2        
11 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
12 2 2 2 2 2 2 2 2 2 2               
13 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2       
14 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2      
15 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2         
16 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2     
17 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
18 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
19 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2    
20 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2   
21 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2    
22 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2   
23 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2    
24 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2    
25 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
26 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2     
27 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2         
28 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2      
29 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2         
30 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
 
 
 
 
 
 
 
 Time in Mins   ADVERSE EFFECTS 
S.NO 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 300 315 330 345 360 
1 NIL NIL NIL NIL NL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL    
2 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL    
3 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL      
4 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL    
5 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL      
6 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL       
7 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL  
8 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL          
9 NIL NIL NIL NIL NIL NIL B B B NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL    
10 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NV NIL NIL NIL         
11 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL       
12 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL               
13 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL       
14 NIL NIL NV NIL NIL NIL NIL NIL NV NIL NIL NIL NIL NIL NIL NIL NIL NIL       
15 NIL NIL NV NIL NIL NIL NIL NIL NV NIL NIL NIL NIL NIL NIL NIL NIL NIL       
16 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL      
17 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL       
18 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL 
19 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL       
20 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL   
21 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL      
22 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL     
23 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL    
24 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL    
25 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL  
26 NL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL      
27 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL      
28 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL      
29 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL     
30 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL     
 Time in Mins   LEVEL OF SENSORY BLOCK            
S.N0 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 300 315 330 345 360
1 T6 T6 T6 T6 T8 T8 T8 T10 T10 T12 T12 L1 L1 L2 L3 L3 L4 L4 L5 L5 S1    
2 T6 T6 T6 T6 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1    
3 T8 T10 T10 T12 T12 T12 L1 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1       
4 T8 T8 T10 T10 T10 T12 T12 T12 L1 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1     
5 T8 T8 T10 T10 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1      
6 T6 T6 T6 T6 T8 T8 T10 T10 T12 L1 L2 L2 L3 L4 L4 L5 L5        
7 T6 T6 T6 T6 T6 T6 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1  
8 T12 T12 T12 L1 L1 L2 L2 L3 L3 L3 L4 L4 L5 L5 S1          
9 T8 T9 T9 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1        
10 T6 T6 T8 T8 T10 T10 T12 L1 L1 L2 L2 L3 L3 L3 L4 L5 L5 S1       
11 T6 T6 T8 T8 T10 T10 T12 L1 L1 L2 L2 L3 L3 L3 L4          
12 T11 T12 T12 L1 L2 L2 L3 L3 L4 L5 S1              
13 T8 T10 T10 T12 T12 L1 L1 L2 L2 L2 L3 L3 L4 L4 L5 L5 L5 S1       
14 T6 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1       
15 T6 T8 T8 T10 T12 T12 L1 L2 L2 L2 L3 L3 L4 L4 L5 S1         
16 T10 T10 T12 T12 T12 L1 L1 L1 L2 L2 L3 L3 L3 L4 L4 L5 L5 L5 S1      
17 T12 T12 L1 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 L5 S1          
18 T8 T8 T8 T8 T10 T10 T12 T12 L1 L1 L1 L2 L2 L2 L3 L3 L3 L4 L4 L4 L5 L5 L5 L5 
19 T10 T10 T12 T12 L1 L1 L1 L2 L2 L3 L3 L4 L4 L5 S1          
20 T8 T8 T8 T10 T10 T10 T12 T12 L1 L1 L1 L2 L2 L3 L3 L3 L4 L4 L5 L5 S1    
21 T8 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L4 L5 L5 S1      
22 T6 T8 T8 T10 T10 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1     
23 T6 T6 T8 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L2 L3 L3 L4 L4 L5 L5 S1    
24 T6 T6 T8 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1     
25 T6 T8 T8 T8 T10 T10 T10 T12 T12 T12 L1 L1 L4 L2 L2 L3 L3 L4 L4 L5 L5 S1   
26 T6 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 L5 S1      
27 T8 T8 T10 T10 T12 T12 L1 L1 L2 L3 L3 L4 L4 L5 L5 S1         
28 T6 T6 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1      
29 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1         
30 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1          
 
 
 
 
 
 
 
 
 Time in Mins    LEVEL OF MOTOR BLOCK   
S.NO 15 30 45 60 75 90 105 120 135 150 165 180 195 
1 B3 B3 B3 B3 B2 B2 B2 B1 B1 B1 BO   
2 B2 B2 B2 B2 B1 B1 B1 B0      
3 B3 B2 B2 B2 B2 B1 B1 B1 B0     
4 B3 B3 B3 B2 B2 B2 B2 B1 B1 B1 B0   
5 B3 B2 B2 B2 B1 B1 B1 B1 B0     
6 B3 B2 B2 B2 B1 B1 BO       
7 B3 B3 B3 B3 B2 B2 B1 B1 B0     
8 B3 B2 B2 B2 B2 B1 B1 B0      
9 B2 B1 B1 B0          
10 B3 B3 B3 B3 B3 B3 B2 B2 B1 B1 B0   
11              
12 B2 B2 B1 B1 B0         
13 B3 B3 B2 B2 B2 B2 B1 B1 B1 B0    
14 B3 B3 B3 B2 B2 B2 B1 B 1 B1 B1 B0   
15 B2 B2 B1 B1 B0         
16 B2 B2 B1 B1 B0         
17 B2 B2 B1 B1 B1 B0        
18 B3 B3 B2 B2 B2 B1 B1 B1 B0     
19 B3 B2 B2 B2 B1 B1 B1 B1 B0     
20 B3 B2 B2 B2 B1 B1 B1 B0      
21 B2 B2 B2 B1 B1 B1 B0       
22 B3 B3 B2 B2 B2 B2 B1 B1 B1 B0    
23 B3 B2 B2 B2 B1 B1 B1 B0      
24 B3 B3 B3 B2 B2 B2 B2 B1 B1 B1 B1 B0  
25 B3 B3 B3 B3 B2 B2 B2 B2 B1 B1 B1 B1 B0 
26 B2 B2 B2 B2 B1 B1 B0       
27 B3 B2 B2 B2 B2 B2 B1 B1 B1 B1 B0   
28 B3 B3 B2 B2 B2 B2 B2 B1 B1 B1 B1 B0  
29 B3 B2 B2 B2 B2 B2 B1 B1 B0     
30 B3 B3 B2 B2 B2 B2 B1 B1 B1 B0    
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RESCUE 
ANALGESIA 
  Group BD 2.8 cc of 0.5% Bupivacaine +5 µg DXM 0.5 cc 
 
      T10 T6 regress to S1 PMB regress TIME IN MINS 
1 60 UVP VH/PFR 1 65 NIL NIL NIL T6 B3 NIL EXC. 3 5 487 7 248 310 
2 47 AUB VH 1 75 NIL NIL NIL T6 B3 NIL EXC. 3 5 512 8 288 275 
3 60 UVP VH/PFR 1 90 NIL NIL NIL T6 B3 NIL EXC. 3 5 390 7 271 300 
4 44 FU VH 1 50 NIL NIL NIL T6 B3 NIL EXC. 3 5 487 7 293 295 
5 39 FU VH 1 65 B A 0.6 NIL T6 B3 NIL EXC. 3 5 436 7 287 285 
6 40 UVP VH/PFR 1 120 V EM 4 NIL T6 B3 NIL EXC. 3 6 465 7 335 190 
7 55 UVP VH/PFR 1 60 NIL NIL NIL T6 B3 NIL EXC. 3 5 480 7 256 320 
8 40 FU VH 1 60 NIL NIL NIL T4 B3 NIL EXC. 3 5 421 6 267 210 
9 49 AUB VH 1 70 NIL NIL NIL T6 B3 NIL EXC. 3 5 564 7 303 305 
10 40 FU VH 1 85 NIL NIL NIL T6 B3 NIL EXC. 2 4 390 6 211 230 
11 41 AUB VH 1 120 NIL NIL NIL T6 B3 NIL EXC. 3 5 549 6 293 297 
12 45 UVP VH/PFR 1 60 H EP 6 NIL T6 B3 NIL EXC. 3 5 396 7 277 210 
13 55 AUB VH 1 85 NIL NIL NIL T6 B3 NIL EXC. 3 6 466 6 362 230 
14 41 AUB VH 1 80 B A 0.6 NIL T6 B3 NIL EXC. 3 5 579 7 272 365 
15 55 AUB VH 1 60 NIL NIL NIL T6 B3 NIL EXC. 3 6 376 6 342 305 
16 48 FU VH 1 45 NIL NIL NIL T6 B3 NIL EXC. 3 4 425 7 300 245 
17 42 AUB VH 1 80 H EP 6 NIL T4 B3 NIL EXC. 3 6 570 7 320 360 
18 40 AUB VH 1 100 NIL NIL NIL T6 B3 NIL EXC. 3 4 380 7 300 280 
19 43 UVP VH/PFR 1 120 NIL NIL NIL T6 B3 NIL EXC. 2 4 489 7 338 270 
20 41 AUB VH 1 80 NIL NIL NIL T6 B3 NIL EXC. 3 5 497 7 280 280 
21 40 FU VH 1 90 H EP 6 NIL T6 B3 NIL EXC. 3 4 437 7 267 280 
22 55 UVP VH/PFR 1 60 NIL NIL NIL T6 B3 NIL EXC. 2 4 490 7 252 135 
23 45 AUB VH 1 80 NIL NIL NIL T6 B3 NIL EXC. 2 5 475 6 325 270 
24 50 UVP VH/PFR 1 80 NIL NIL NIL T4 B3 NIL EXC. 2 5 400 6 277 250 
25 60 UVP VH/PFR 1 55 NIL NIL NIL T6 B3 NIL EXC. 2 4 430 5 280 320 
26 45 AUB VH 1 65 NIL NIL NIL T6 B3 nil EXC. 2 4 450 5 290 305 
27 48 AUB VH 1 70 NIL NIL NIL T6 B3 NIL EXC. 2 4 465 6 270 335 
28 42 FU VH 1 65 B A 0.6 NL T6 B3 NIL EXC. 2 4 425 6 290 305 
29 50 UVP VH/PFR 1 80 NIL NIL NIL T6 B3 NIL EXC. 2 4 440 6 285 280 
30 52 UVP VH/PFR 1 70 NIL NIL NIL T6 B3 NIL EXC. 3 5 400 6 280 260 
 
POST OP MONITORING GROUP D 
 Basal Time in Mins  Heart Rate 
S.NO 15 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 300 315 330 345 360 375 390 405 420 435 450 
1 86 86 86 88 84 83 82 81 80 88 84 86 88 86 88 86 84 83 82 81 80 88 87 86 88 88 90 88 86   
2 80 80 85 88 90 92 94 92 90 90 86 88 90 92 90 92 90 80 86 88 84 88 90 92 90 92 90 92 90   
3 96 96 90 88 86 84 82 80 88 82 80 94 92 93 90 92 94 96 94 96 93           
4 94 94 96 94 91 90 88 72 90 92 90 90 90 92 90 99 96 98 96 94 93 90 88 86 88 84 82 88 86 78 86 
5 82 82 84 80 84 84 82 78 82 84 86 86 92 92 94 90 88 88 88 86 88 86 86 86 86       
6 69 69 71 75 70 73 66 67 68 68 75 68 67 79 67 65 65 64 68 68 64           
7 68 68 64 66 72 71 74 74 72 72 72 71 70 68 68 64 64 64 64 60 62 60 72 78 72 78      
8 80 80 82 82 84 84 84 88 78 76 76 76 78 80 80 82 88 86              
9 68 68 70 68 72 72 70 68 64 68 70 72 74 78 65 66 74 72 70 80 72 72 78 78 78 80 82 86 72 72 74 
10 90 90 82 83 86 93 82 88 74 73 68 62 68 78 78 71 67 70 66 68            
11 82 82 80 82 80 82 80 82 82 84 88 86 88 86 88 86 88 86 86 88            
12 80 80 78 78 78 76 76 74 72 70 72 72 72 71 70 69 72 74 76 78            
13 62 62 64 62 80 82 70 72 70 72 70 70 72 72 70 70 72 70 72 68            
14 72 72 70 68 70 62 72 70 64 64 64 64 72 74 78 76 76 74 72 74 72 70 70 72 70 72 70 72    
15 88 88 86 84 88 82 90 90 90 90 88 88 86 84 72 80 88 84 81             
16 65 65 64 63 60 65 65 65 71 72 73 75 78 81 84 85 84 85 86 88 86 88 84 84 84 84 86     
17 78 78 80 82 84 80 82 88 86 88 86 90 91 91 90 90 92 91 92 91 91 91 90 87 87 87 86 86 86   
18 68 68 64 68 64 64 74 72 72 70 70 68 66 67 66 68 66 78 72 74 74 76 84         
19 64 64 65 64 62 64 68 68 72 70 72 72 74 74 74 80 82 80 80 80 78 78 76 76        
20 77 77 78 77 77 82 80 82 78 73 78 78 82 83 77 73 72 71 72 70 71 70 68 70 72 74 76 76    
21 84 84 82 82 80 82 84 82 84 88 84 82 81 82 81 84 82 82 82 80 82 80          
22 68 68 72 74 68 74 72 70 68 64 62 68 72 71 76 68 64 62 61 60 62 62 62 64 64       
23 72 72 74 76 78 74 76 78 76 78 76 74 68 64 66 62 60 62 68 64 66 64 63 72 70 78      
24 72 72 74 70 68 72 70 68 74 76 72 72 70 71 71 70 72 72 70 70 72 72          
25 86 86 88 88 87 82 83 84 88 87 89 86 88 86 88 86 84 83 82 81 80 88 87 86 88       
26 96 96 90 88 86 84 83 82 86 88 86 88 90 92 90 92 90 80 86 88 88 86 84 84 88 86 88     
27 79 79 71 75 70 73 66 67 78 68 75 68 67 79 67 65 65 64 68 68 64 72 72 78 78 80 82 86    
28 82 82 80 82 82 84 84 84 84 88 86 86 88 86 86 86 84 84 84 84 82 78 78 76 76       
29 70 70 72 70 70 71 74 62 72 69 68 68 71 71 72 72 76 76 76 76 77 78 78 84 88       
30 80 80 78 78 80 82 82 84 84 82 82 81 81 80 78 78 78 80 76 76 78 82 82         
 
  Time in Mins  BLOOD PRESSURE 
S 
No Basal 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 300 315 330 345 360 375 390 405 420 435 450 
1 110/70 110/70 120/80 110/70 110/70 110/80 120/80 130/80 110/70 120/80 110/70 120/80 110/70 110/70 120/80 110/70 130/80 120/80 110/70 110/70 110/70 120/80 120/80 120/80 130/80 125/78 120/80 130/80 130/80   
2 118/78 118/78 120/78 120/80 118/78 120/80 120/80 130/80 120/80 118/78 120/80 120/80 120/78 130/80 128/78 118/78 120/80 120/80 118/78 120/80 118/78 118/80 120/80 120/80 120/80 130/80 130/80 140/80 140/80   
3 110/70 110/70 110/70 110/70 120/80 130/80 130/80 128/80 130/70 120/80 110/70 110/70 120/80 118/78 110/78 120/80 128/80 118/78 120/80 130/80 130/80           
4 120/80 120/80 123/80 123/86 117/81 120/80 120/90 120/80 120/80 110/80 116/79 120/80 110/80 123/80 123/80 120/80 117/80 120/80 117/81 119/81 119/80 120/80 120/80 120/70 110/80 116/79 120/80 110/70 110/70 120/80 120/80 
5 110/70 110/70 110/68 106/68 114/73 118/90 118/72 118/90 114/73 114/78 123/70 120/80 118/72 118/80 120/80 118/78 110/70 120/80 118/78 114/78 114/78 118/80 120/80 130/90 130/90       
6 113/64 113/64 114/78 115/75 112/81 103/80 101/68 106/68 105/65 106/64 104/63 101/65 106/64 104/73 111/79 103/86 99/63 108/62 118/67 113/60 110/70           
7 130/80 130/80 110/80 120/80 110/70 110/70 120/78 120/80 98/70 98/70 100/70 100/70 100/60 100/60 100/60 110/70 110/70 110/70 120/80 120/80 118/78 110/80 128/80 130/80 130/80 130/80      
8 140/80 140/80 140/80 150/90 140/80 160/90 150/90 140/80 140/80 140/80 150/90 150/90 150/80 140/80 140/80 150/80 150/80 150/80              
9 120/70 120/70 110/80 130/70 130/90 130/70 130/70 120/80 110/68 110/70 110/80 130/80 140/80 130/80 110/70 120/80 130/80 130/80 130/90 130/90 128/78 115/78 120/80 110/70 110/70 120/80 120/70 120/80 110/70 110/80 110/80 
10 125/85 125/85 119/81 119/81 123/84 107/71 110/73 115/69 115/69 117/60 98/72 115/72 120/78 130/80 125/80 120/80 121/82 121/82 120/76 116/78            
11 140/80 140/80 130/80 140/80 130/80 130/80 120/80 128/78 130/80 132/80 130/80 130/80 128/78 128/78 120/80 130/80 130/80 130/80 130/80 130/80            
12 100/70 100/70 110/70 110/70 108/68 110/70 110/72 100/70 110/72 118/75 116/78 110/70 110/70 120/80 120/80 110/70 110/70 110/70 110/70 110/70            
13 110/70 110/70 110/70 100/70 110/70 110/72 118/78 118/80 120/80 118/78 116/78 112/70 112/72 110/68 110/70 120/78 110/78 120/80 120/80 120/80            
14 90/70 90/70 90/70 90/70 94/70 94/70 98/70 95/70 96/70 96/70 96/70 96/70 96/70 110/80 110/80 100/70 100/60 110/80 110/70 100/72 100/72 100/70 110/80 100/80 110/80 110/70 110/70     
15 100/70 100/70 100/70 110/70 120/70 120/70 110/70 110/70 110/80 120/70 120/70 110/70 110/70 110/70 110/70 120/80 130/80 140/80 140/80             
16 98/63 98/63 96/60 98/70 100/70 105/69 100/68 110/70 110/70 110/72 110/80 110/80 110/70 110/70 120/80 120/78 130/80 140/78 140/80 130/78 130/80 130/80 130/80 130/80 128/78 130/80 130/80     
17 90/60 90/60 90/60 92/62 99/60 99/59 90/60 100/60 102/63 100/60 110/70 110/70 110/70 110/70 110/70 120/80 120/80 120/80 120/80 120/80 120/80 110/80 110/70 110/80 110/80 110/80 110/80 110/80 120/80   
18 110/70 110/70 108/68 110/70 110/70 100/70 100/70 110/80 100/70 120/80 110/70 120/80 110/70 110/70 120/80 110/80 110/80 110/70 110/80 110/70 110/70 110/70 120/80         
19 100/70 100/70 100/70 110/70 110/68 110/70 130/80 130/80 130/80 130/80 130/80 120/80 110/70 110/70 110/70 100/70 110/70 130/80 120/78 120/80 130/78 130/80 130/80 130/80        
20 110/70 110/70 110/70 120/80 120/80 120/80 110/70 110/70 120/80 130/80 120/70 120/70 110/80 110/80 110/70 120/80 128/78 118/78 120/80 130/80 130/78 130/78 130/80 130/80 130/80 128/78 128/78 128/78    
21 120/70 120/70 110/80 110/80 108/70 110/78 120/80 120/78 130/80 110/78 110/78 110/78 120/80 118/78 120/78 110/78 118/78 108/80 110/80 110/70 110/70 120/80          
22 110/80 110/80 120/80 110/70 120/80 110/80 110/70 120/80 118/78 128/78 120/78 120/80 118/80 118/80 120/80 120/80 130/80 128/78 120/80 130/80 130/80 130/80 130/80 130/80 130/80       
23 110/80 110/80 110/80 120/80 120/80 118/78 120/80 128/78 124/73 131/99 130/90 124/83 130/80 130/80 140/80 140/80 131/97 124/83 124/83 117/77 120/80 110/78 124/83 124/83 130/80 131/90 130/90 130/90    
24 110/70 110/70 120/80 120/80 120/80 120/80 130/80 130/80 128/78 120/80 110/80 120/80 120/80 120/80 120/70 120/80 120/80 130/80 130/80 120/70 128/78 120/80          
25 120/70 120/70 120/80 120/80 110/70 120/70 110/78 120/80 130/80 120/80 110/70 110/78 120/80 110/78 120/80 120/80 120/80 120/80 130/80 130/80 128/78 120/70 130/80 120/80 130/80       
26 118/70 118/70 128/80 120/80 130/80 120/70 128/78 130/80 118/78 110/70 110/70 110/78 120/80 110/78 120/80 120/80 128/80 128/78 130/80 130/80 120/78 128/80 128/80 120/80 130/80 139/80 130/80     
27 130/80 130/80 128/78 120/80 130/80 140/80 138/80 140/80 140/80 130/80 130/80 130/80 130/80 140/80 140/80 140/80 142/78 140/78 138/78 140/80 140/80 140/80 140/80 140/80 130/80       
28 130/80 130/80 130/78 130/80 130/78 128/80 128/78 120/78 118/78 120/80 120/80 130/70 130/78 140/80 130/80/ 138/80 140/80 140/78 130/80 130/78 130/70 138/78 138/78 140/80 140/80       
29 108/67 108/67 110/70 110/70 110/70 110/70 110/68 118/78 118/72 118/76 120/80 120/80 120/80 128/78 130/80 130/80 130/80               
30 108/67 108/67 110/70 110/70 110/70 110/70 110/68 118/78 118/72 118/76 120/80 120/80 120/80 128/78 130/80 130/80 130/80               
 
 Time in Mins   PAIN SCORE 
S No 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 300 315 330 345 360 375 390 405 420 435 
1 0 0 0 0 0 0 0 0 0 0 0 1 1 2 2 2 2 2 2 1 1 1 1 1 0 0 0 0  
2 0 0 0 0 0 0 0 0 0 0 1 1 2 2 2 2 2 2 2 1 1 1 1 1 0 0 0   
3 0 0 0 0 0 0      1 1 2 2 2 2 2 1 1 1 1 0       
4 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 2 2 2 2 2 2 2 2 1 1 1 1 0 0 
5 0 0 0 0 0 0 0 0 0 1 1 2 2 2 2 1 1 1 1 0 0 0 0 0      
6 1 2 2 2 2 2 1 1 1 1 1 0 0 0 0 0 0 0 0 0          
7 0 0 0 0 0 0 0 0 0 0 0 1 1 2 2 2 2 2 1 1 1 0 0 0 0     
8 1 1 2 2 2 2 1 1 1 1 1 1 0 0 0 0 0             
9 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2 2 2 2 2 2 1 1 1 1 1 0 0 0 0 
10 0 0 0 0 0 0 1 2 2 2 2 2 1 1 1 0 0 0 0           
11 0 0 0 0 0 0 0 1 1 2 2 2 2 1 1 1 1 0 0 0          
12 0 0 0 0 2 2 2 2 2 1 1 1 1 0 0 0 0 0            
13 0 0 0 0 1 1 2 2 2 1 1 1 1 1 0 0 0 0 0           
14 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2 2 2 2 2 1 1 1 0 0      
15 0 0 0 0 0 0 2 2 2 2 2 1 1 1 1 0              
16 0 0 0 0 0 0 0 1 1 1 1 1 2 2 2 2 2 1 1 1 1 0        
17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 2 2 1 1 1 1 0      
18 0 0 0 0 0 0 0 0 0 0 0 1 1 2 2 2 2 1 1 1 0         
19 0 0 0 0 0 0 1 1 1 2 2 2 2 2 2 1 1 1 1 0          
20 0 0 0 0 0 0 1 1 1 1 2 2 2 2 2 2 1 1 1 1 1 1 0       
21 0 0 0 0 0 0 1 1 1 2 2 2 2 2 2 2 1 1 1 0          
22 0 1 1 1 2 2 2 2 2 2 2 2 2 2 1 1 1 1 0           
23 0 0 0 0 0 0 0 0 0 1 1 1 2 2 2 2 2 2 1 1 1 1 0       
24 0 0 0 0 0 0 0 0 1 1 2 2 2 2 2 2 2 1 1 1 0         
25 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 2 2 1 1 1 1 1 0 0      
26 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2 2 2 1 1 1 1 1 1 0 0 0    
27 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2 2 1 1 1 1 1 0 0 0 0   
28 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 2 1 1 1 1 1 0 0 0      
29 0 0 0 0 0 0 0 0 0 0 1 0 1 2 1 1 1 1 1 1 0 0 0 0      
30 0 0 0 0 0 0 0 0 0 1 1 1 2 2 2 1 1 1 1 0 0 0        
 
  
 Time in Mins    LEVEL OF MOTOR BLOCK 
S No 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 
1 B3 B3 B3 B3 B3 B2 B2 B2 B2 B2 B1 B1 B1 B0      
2 B3 B3 B3 B3 B3 B2 B2 B2 B2 B2 B1 B1 B1 B0      
3 B3 B3 B2 B2 B2 B2 B2 B1 B1 B1 B1 B0        
4 B3 B3 B3 B3 B3 B3 B2 B2 B2 B2 B2 B1 B1 B1 B1 B1 B0   
5 B3 B3 B3 B3 B2 B2 B2 B2 B1 B1 B1 B1 B0       
6 B2 B2 B2 B2 B2 B2 B1 B1 B1 B1 B0         
7 B3 B3 B3 B3 B3 B2 B2 B1 B1 B0          
8 B1 B1 B1 B1 B1 B1 B0             
9 B3 B3 B3 B3 B3 B3 B3 B3 B2 B2 B2 B1 B1 B0      
10 B3 B3 B2 B2 B1 B1 B0             
11 B3 B3 B3 B3 B3 B2 B2 B2 B1 B1 B0         
12 B3 B3 B3 B2 B2 B2 B1 B1 B0           
13 B3 B3 B3 B3 B3 B2 B2 B1 B1 B1 B1 B0        
14 B3 B3 B3 B2 B2 B2 B2 B1 B1 B1 B1 B1 B1 B1 B0     
15 B3 B3 B2 B2 B2 B1 B1 B1 B1 B1 B0         
16 B3 B3 B3 B3 B3 B3 B3 B3 B2 B2 B2 B2 B2 B2 B2 B1 B1 B1 B0 
17 B3 B3 B3 B3 B3 B3 B2 B2 B2 B2 B2 B1 B1 B1 B0     
18 B3 B3 B3 B3 B3 B2 B2 B2 B1 B1 B1 B1 B1 B1 B0     
19 B3 B3 B3 B3 B2 B2 B2 B1 B1 B1 B1 B1 B0       
20 B3 B3 B3 B3 B3 B3 B3 B2 B2 B1 B1 B1 B0       
21 B3 B3 B3 B2 B2 B2 B1 B1 B1 B0          
22 B3 B3 B3 B3 B3 B2 B2 B2 B2 B1 B1 B0        
23 B3 B3 B3 B3 B3 B2 B2 B2 B2 B2 B1 B1 B1 B1 B1 B0    
24 B3 B3 B3 B3 B3 B2 B2 B2 B2 B1 B0 B0        
25 B3 B3 B3 B3 B2 B2 B2 B2 B2 B1 B1 B1 B1 B0      
26 B3 B3 B3 B3 B2 B2 B2 B2 B2 B1 B1 B1 B1 B1 B0     
27 B3 B3 B3 B2 B2 B2 B2 B2 B1 B1 B1 B1 B1 B0      
28 B3 B3 B3 B3 B3 B2 B2 B2 B2 B2 B2 B1 B1 B1 B0     
29 B3 B3 B3 B3 B2 B2 B2 B2 B1 B1 B1 B1 B1 B0      
30 B3 B3 B3 B3 B2 B2 B2 B2 B2 B1 B1 B1 B1 B0      
 
  
 Time in Mins      LEVEL OF SENSORY BLOCK 
S.NO 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 300 315 330 345 360 375 390 405 420 435 450 
1 T6 T6 T8 T8 T8 T10 T10 T10 T10 T12 T12 T12 T12 L1 L1 L2 L2 L3 L3 L3 L4 L4 L5 L5 L5 S1     
2 T6 T8 T8 T8 T8 T10 T10 T10 T12 T12 T12 T12 L1 L1 L1 L2 L2 L2 L3 L3 L3 L4 L4 L4 L4 L5 L5 S1   
3 T6 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L3 L4 L4 L4 L5 L5 1  S            
4 T6 T6 T8 T8 T8 T10 T10 T10 T10 T12 T12 T12 L1 L1 L1 L1 L1 L1 L2 L2 L3 L3 L3 L4 L4 L4 L5 L5 L5 S1 
5 T6 T8 T6 T6 T6 T8 T8 T8 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L4 L4 L5 L5 S1       
6 T6 T8 T8 T10 T10 T12 T12 L1 L2 L2 L2 L2 L3 L3 L3 L4 L4 L5 L5 1  S            
7 T6 T8 T8 T10 T10 T12 T12 T12 T12 L1 L1 L1 L1 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1       
8 T10 T10 T10 T12 T12 L1 L2 L2 L3 L3 L4 L4 L4 4 L5 L5 1 L    S               
9 T6 T6 T6 T8 T8 T8 T10 T10 T10 T12 T12 L1 L1 L2 L2 L2 L2 L2 L2 L3 L3 L3 L3 L4 L4 L4 L4 L5 L5 S1 
10 T8 T8 T10 T10 T12 T12 T12 L1 L1 L1 L2 L3 L3 L4 L4 L5 L5 S1             
11 T6 T6 T6 T8 T8 T8 T10 T10 T12 T12 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1           
12 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L2 L3 L3 L3 L4 L4 L5 S1             
13 T8 T8 T10 T10 T12 T12 T12 T12 L1 L1 L2 L3 L3 L4 L4 L5 L5 L5 S1            
14 T6 T6 T6 T8 T8 T8 T8 T10 T10 T10 T12 T12 L1 L2 L2 L2 L3 L3 L3 L4 L4 L4 L5 L5 L5 S1     
15 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 L5 S1             
16 T6 T6 T6 T10 T8 T8 T8 T8 T10 T10 T10 T10 T12 T12 L1 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1     
17 T6 T6 T6 T8 T8 T8 T8 T10 T10 T10 T10 T12 T12 T12 L1 L1 L1 L2 L2 L3 L3 L4 L4 L4 L5 L5 L5 S1   
18 T6 T6 T6 T8 T8 T8 T10 T10 T12 T12 L1L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 L5 S1         
19 T8 T8 T10 T10 T10 T12 T12 T12 L1 L1 T12 L2 L2 L2 L2 L3 L3 L3 L4 L4 L5 L5 S1        
20 T6 T6 T6 T8 T8 T8 T8 T10 T10 T10 L1 T12 T12 T12 L1 L1 L1 L2 L2 L2 L3 L3 L4 L4 L5 L5 S1    
21 T6 T8 T8 T8 T10 T10 T12 T12 L1 L1 T12 L2 L2 L2 L3 L3 L4 L4 L5 L5 S1          
22 T6 T6 T6 T6 T8 T8 T8 T10 T10 T12 T12 L1 L1 L1 L2 L2 L2 L3 L3 L4 L4 L5 L5 S1       
23 T6 T6 T6 T8 T8 T8 T8 T10 T10 T10 T12 T12 T12 L1 L1 L2 L2 L2 L2 L3 L3 L4 L4 L5 L5 S1     
24 T6 T6 T6 T8 T8 T10 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1          
25 T6 T6 T6 T6 T6 T6 T8 T8 T10 T10 T12 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1       
26 T6 T6 T8 T8 T8 T10 T10 T12 T12 T12 L1 L1 L1 L2 L2 L2 L3 L3 L3 L4 L4 L4 L5 L5 L5 S1     
27 T6 T6 T6 T8 T8 T8 T10 T10 T10 T12 T12 T12 L1 L1 L1 L2 L2 L2 L3 L3 L4 L4 L5 L5 L5 S1     
28 T6 T6 T8 T8 T8 T8 T10 T10 T10 T12 T12 T12 L1 L1 L1 L2 L2 L3 L3 L4 L4 L5 L5 S1       
29 T6 T6 T8 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L4 L4 L4 L5 L5 L5 L5 L5 S1       
30 T6 T6 T8 T8 T10 T10 T12 T12 L1 L1 L2 L2 L3 L3 L3 L4 L4 L4 L5 L5 L5 S1         
 
INTRAOP VITALS MONITORING GROUP D 
  Time in Mins  HEART RATE 
SL.NO Basal 5 10 15 20 25 30 35 40 45 60 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 140 145 
1 97 97 94 94 90 92 88 86 87 81 80 80 84 86 82 81 70 77 76 78 80          
2 88 88 86 84 79 75 79 77 78 77 79 77 78 75 75 74 73              
3 85 85 88 79 76 87 86 76 86 76 86 78 84 83 73 73 74 72 72 71 80          
4 96 96 98 94 92 90 88 84 80 82 81 80 82                  
5 82 82 84 80 82 84 80 76 76 76 73 60 47 60 68 70 72 70             
6 98 98 89 96 82 82 84 88 85 94 76 71 80 70 80 70 88 78 80 82 84 72 72 84 76 76 76 72 70 80 
7 81 81 80 78 78 76 74 74 76 67 65 64 66 64 64 78 68              
8 80 80 76 74 76 76 71 76 74 74 74 79 71 72 77 77 83 74 69 74 74 74 85 85 82 89 88 86 80 80 
9 100 100 86 84 84 84 75 84 74 72 72 79 75 74 72 72 72 70 71 72 72          
10 105 105 91 80 78 73 71 72 74 75 75 78 78 81 84 85 82 80 81 84 78 85 86        
11 90 90 91 89 88 86 88 96 97 98 97 84 88 89 90 82 80 81 87 86 86 84 83 82 80      
12 80 80 76 72 74 76 72 75 75 77 86 74 75 69 78 78 80 77 78 82 79          
13 113 113 98 95 98 99 86 77 76 81 89 79 82 84 79 82 82 83 80 84 77          
14 110 110 105 83 106 83 86 86 63 46 70 72 70 85 82 88 89 88 86 88 84          
15 104 104 103 102 98 99 92 92 91 91 101 102 102 101 101 96 97 97 97 97 99          
16 80 80 86 79 78 71 78 71 70 65 69 68 68                  
17 90 90 80 82 84 84 82 78 78 78 83 82 80 83 83 82 80 81 82            
18 74 74 74 89 93 88 84 86 85 87 81 79 79 78 78 78 74 74 72 78 74          
19 71 71 68 64 64 64 64 64 63 62 60 69 72 82 60 67 68 68 62 62 62 59 66 66 66 66 66    
20 78 78 75 74 74 74 71 72 76 81 81 79 78 71 76 78 74 72 70 66 66          
21 110 110 104 96 98 94 80 82 80 78 78 70 82 85 84 83 79 82 79 70 83 83 70 79       
22 69 69 62 68 70 72 64 68 62 62 64 62 65 66 68 62 60              
23 65 65 64 63 62 60 60 62 64 62 68 68 68 65 60 65 64 63 62 60           
24 76 76 77 72 77 68 70 72 74 73 72 72 72 73 72 70 68 68 67 68 70          
25 76 76 77 72 77 68 70 72 74 73 72 72 72 73 72 70 68              
26 88 88 86 84 79 75 79 77 78 77 79 77 78 75                 
27 80 80 80 78 78 76 74 76 76 76 79 75 71 72 70                
28 92 92 91 88 86 77 75 74 68 62 49 68 72 77                 
29 76 76 77 74 72 70 75 74 73 72 76 78 80 72 74 71 70              
30 72 72 72 70 76 74 71 72 70 72 68 70 68 74 76                
 
  Time in Mins BLOOD PRESSURE 
S.NO Basal 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 140 145 
1 150/90 150/90 150/90 143/98 134/100 138/94 138/94 116/91 126/88 120/90 129/88 130/86 116/80 110/80 130/80 128/80 129/90 130/80 120/80 128/80 116/80          
2 150/90 150/90 140/80 130/80 140/80 160/90 140/90 130/80 140/80 150/80 140/80 130/80 120/80 120/80 120/80 120/80 110/70              
3 150/90 150/90 145/80 160/80 130/80 106/73 104/72 97/67 97/70 96/67 100/67 97/64 100/67 102/79 101/66 99/63 106/73 104/72 130/80 120/80 110/80          
4 160/90 160/90 160/90 150/90 140/80 128/83 128/75 116/61 128/83 120/80 116/61 110/70 120/80 128/83                 
5 140/90 140/90 120/80 100/60 100/60 118/72 118/70 115/78 114/73 110/70 102/65 100/70 106/68 100/70 106/68 110/68 104/73 110/70             
6 111/65 111/65 113/79 106/69 122/71 108/76 112/70 96/53 91/59 109/65 98/60 101/57 108/69 102/65 102/66 107/61 101/57 112/67 99/58 101/76 105/54 101/68 97/62 94/47 99/55 94/56 92/54 90/50 90/60 100/70
7 150/90 150/90 141/90 122/75 107/74 102/68 105/73 104/78 96/71 105/69 98/65 96/66 94/66 92/63 95/66 92/64 102/71              
8 140/80 140/80 130/78 120/80 140/80 140/78 150/80 120/78 130/70 120/78 130/80 130/80 110/70 130/80 130/80 120/78 130/80 130/80 120/78 130/80 110/70 110/70 120/70 120/70 120/78 110/70 100/70 100/70 110/70 110/70
9 140/90 140/90 135/80 135/80 128/74 128/74 111/72 119/71 121/66 120/72 121/66 119/71 117/71 119/71 116/71 116/70 118/80 120/80 120/80            
10 100/80 100/80 116/72 98/60 99/58 108/69 108/69 112/67 115/70 115/73 115/70 112/70 114/74 112/72 110/75 113/78 112/82 118/82 118/81 115/81 119/75 114/83 111/76        
11 135/99 135/99 126/91 107/76 113/84 111/82 111/80 114/83 106/81 105/76 108/78 109/69 103/70 109/69 107/60 110/66 106/67 113/76 111/68 123/75 109/66 113/76 105/86 111/86 109/66      
12 120/80 120/80 117/70 110/70 109/65 109/67 109/65 109/65 106/72 103/59 100/71 97/57 93/53 88/40 94/50 96/47 103/58 103/59 103/58 88/52 102/59          
13 150/90 150/90 140/90 130/90 120/80 124/78 113/67 113/67 105/67 109/67 104/64 109/74 101/67 109/74 108/66 107/63 99/66 98/67 110/70 110/72 120/80          
14 144/88 144/88 130/81 130/75 117/66 108/71 107/68 107/67 106/62 106/62 103/61 106/68 103/54 94/54 98/55 98/58 100/60 108/68 108/68 103/54 110/70          
15 154/85 154/85 145/76 130/75 124/71 123/71 123/71 123/71 124/74 117/71 105/65 111/69 120/69 122/73 117/72 117/69 117/71 122/72 121/72 120/79 121/71          
16 150/90 150/90 130/80 110/60 103/77 104/64 105/69 102/66 102/66 102/66 98/63 98/63 98/63                  
17 140/80 140/80 150/90 120/70 95/55 100/60 102/63 99/59 99/54 101/63 93/65 87/53 92/58 101/63 100/60 101/63 90/55 90/60 100/60            
18 134/88 134/88 134/88 135/77 123/81 125/77 123/81 125/77 125/77 117/64 113/72 110/67 105/67 108/67 110/67 110/67 108/67 112/67 112/67 105/69 104/68          
19 130/80 130/80 110/76 109/75 123/74 103/78 114/60 116/87 103/73 105/67 105/60 105/67 112/61 108/71 114/63 122/67 114/79 122/78 121/75 121/73 120/77 116/81 120/80 120/80 120/80      
20 130/77 130/77 129/87 134/83 124/69 115/72 108/67 105/63 107/62 105/58 104/58 101/56 108/60 102/54 112/70 104/67 104/67 115/72 108/67 105/63 107/62          
21 137/82 137/82 131/93 150/80 107/71 100/71 99/72 100/68 100/68 100/70 80/60 100/68 98/68 103/68 80/60 100/70 110/70 110/70 100/71 100/71 100/71 110/70 120/80 120/80       
22 140/90 140/90 130/80 120/70 110/70 110/70 110/72 110/70 100/60 110/70 120/80 110/72 110/70 112/78 120/80 110/70 110/70              
23 140/80 140/80 130/96 131/99 131/97 124/83 124/83 124/83 117/77 114/72 113/72 111/70 110/70 120/80 130/80 131/97 124/83 120/80 124/83            
24 150/80 150/80 138/87 139/96 134/85 122/86 125/84 124/78 122/86 120/82 113/77 111/70 115/77 122/80 125/84 124/78 122/80 120/82 113/77 110/70 120/80          
25 130/80 130/80 120/80 117/80 118/70 103/78 110/70 110/72 108/67 116/61 110/70 112/68 110/70 118/68 120/72 128/70 110/78              
26 140/90 140/90 142/78 140/80 130/80 120/70 126/72 110/70 118/78 106/73 108/70 100/67 110/70 110/70                 
27 150/90 150/90 150/90 148/78 140/70 148/88 150/80 150/80 150/80 140/90 130/70 130/80 120/80 120/80 120/80                
28 111/70 111/70 113/69 106/69 100/60 98/68 98/68 97/67 97/70 100/64 97/64 118/78 102/70 102/79                 
29 135/99 135/99 126/91 120/90 112/71 104/67 104/72 97/67 97/70 100/67 97/64 100/67 102/79 101/66 101/66 101/66               
30 120/80 120/80 110/70 117/70 109/65 109/67 109/65 108/69 104/78 96/67 96/66 98/60 100/67 100/67 110/70                
 
  
 Time in Mins   ADVERSE EFFECTS 
S.No 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 300 315 330 345 360 375 390 405 420 435 
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
3 NV NV NV NV NV NV NV 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0       
4 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
5 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0      
6 NV NV NV NV 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0          
7 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0     
8 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0             
9 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
10 NV NV NV NV NV 0 0 0 0 0 0 NV NV 0 0 0 0 0 0           
11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0             
12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0            
13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0           
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0     
15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0            
16 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0    
17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0   
18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0        
19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0       
20 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0   
21 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0         
22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0      
23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0    
24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0        
25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0      
26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0    
27 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0     
28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0     
29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0     
30 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0     
 
  
 Time in Mins  RSS 
S.NO 15 30 45 60 75 90 105 120 135 150 165 180 195 210 225 240 255 270 285 300 315 330 345 360 375 390 405 420 435 
1 3 3 3 3 3 3 3 2 2 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2  
2 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2  
3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2       
4 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
5 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2      
6 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2      
7 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2       
8 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2             
9 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
10 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2           
11 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2          
12 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2           
13 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2           
14 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2     
15 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2             
16 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2     
17 2 2 2 2 2 2 2 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2  
18 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2        
19 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2       
20 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2   
21 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2         
22 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2     
23 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2    
24 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2         
25 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2      
26 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2    
27 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2   
28 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2     
29 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2      
30 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2        
 
 Time in Mins  SIDE EFFECTS 
SL.NO 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 140 145 150 
1 NIL NIL NIL NIL NL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL           
2 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL               
3 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL           
4 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NI  L ILN                    
5 NIL NIL NIL NIL N NIL NIL NIL NIL NIL NIL B NIL NIL NIL NIL NIL              
6 NIL NIL NIL NIL NIL NIL NV NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NV NIL NIL NIL NIL NIL NIL NIL 
7 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL              
8 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL 
9 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL           
10 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL N  IL         
11 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL N  IL IL ILN  N              
12 NIL NIL NIL NIL NL NIL NIL NIL NIL NIL NIL NV NIL NIL NIL NIL NIL NIL NV NIL   NIL        
13 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NI  L IL IL ILN  N   N            
14 NIL NIL NIL NIL NIL NIL NIL NIL B NIL NIL NIL NIL NIL NIL NIL NIL NIL  NL           
15 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL N  IL IL ILN  N              
16 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL                 
17 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL H NIL NIL NIL NIL NIL NI  L IL ILN  N             
18 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NI  L IL IL ILN  N   N            
19 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NI  L IL IL NLN  N              
20 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NI  L IL IL ILN  N   N            
21 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL H NIL NIL NIL H NIL NIL NIL    N  IL         
22 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL N  IL IL ILN  N              
23 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NI  L IL IL ILN  N  N             
24 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NI  L IL IL ILN  N   N            
25 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL N  IL IL ILN  N              
26 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NI  L IL ILN  N                   
27 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL                
28 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NI  L IL B ILN   N                  
29 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL N  IL ILN                
30 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL                 
 
 Time in Mins   RSS 
SL.NO 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 140 145 
1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2              
3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
4 2 2 2 2 2 2 2 2 2 2 2 2                  
5 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2             
6 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
7 2 2 2 2 3 2 2 2 2 2 2 2 2 2 2 2              
8 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
9 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 2 2 2          
10 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2        
11 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2        
12 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
13 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
14 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
15 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2            
16 2 2 2 2 2 2 2 2 2 2 2 2                  
17 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2           
18 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
19 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2     
20 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
21 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2       
22 2 2 2 2 2 2 2 2 2 3 2 2 2 2 2 2              
23 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2          
24 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2         
25 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2              
26 2 2 2 2 2 2 2 2 2 2 2 2 2                 
27 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2              
28 2 2 2 2 2 2 2 2 2 2 2 2 2                 
29 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2              
30 2 2 2 2 2 2 2 3 2 2 2 2 2 2                
 
 Time in Mins  RESPIRATORY RATE 
S.NO 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 140 145
1 12 14 16 12 12 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14          
2 14 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12              
3 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14          
4 12 12 12 12 12 12 12 12 12 12 12 12                  
5 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12             
6 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 
7 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14              
8 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 
9 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12          
10 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12        
11 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12        
12 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14          
13 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14          
14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14          
15 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14             
16 12 12 12 12 12 12 12 12 12 12 12 12                  
17 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12            
18 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14          
19 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14     
20 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12          
21 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12       
22 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12              
23 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14           
24 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14          
25 12 12 12 14 16 14 16 17 12 12 12 14 14 12 14 14              
26 12 12 14 16 16 14 14 14 12 12 12 12 12                 
27 14 14 16 16 16 17 17 16 16 14 14 12 12 12                
28 14 14 14 14 14 12 12 12 12 12 12 13 12                 
29 16 14 14 16 14 14 12 12 12 12 12 12 12 12 12 12              
30 13 14 14 12 12 12 12 14 14 14 12 12 14 14                
 
 Time in Mins   SPO2 
SL.NO 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 140 145 
1 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99%          
2 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99%              
3 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98%          
4 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99  % %99                   
5 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%             
6 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 
7 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99%             
8 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 
9 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98%          
10 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%        
11 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%        
12 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99%          
13 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99%          
14 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99%          
15 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%            
16 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99  % %99                   
17 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99%            
18 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99%          
19 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99%     
20 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%          
21 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%       
22 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99%              
23 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99%           
24 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99%          
25 99% 99% 98% 100% 99% 99% 98% 99% 99% 98% 99% 99% 99% 100% 99% 99%              
26 99% 99% 98% 99% 100% 99% 99% 98% 99% 98% 98% 99% 99%                 
27 99% 99% 99% 98% 99% 98% 99% 97% 99% 99% 99% 98% 99% 99%                
28 100% 99% 99% 99% 98% 100% 97% 99% 99% 99% 98% 98% 99%                 
29 100% 99% 99% 99% 98% 99% 98% 98% 99% 99% 98% 98% 97% 98% 99% 98%              
30 97% 98% 99% 99% 98% 99% 99% 99% 99% 99% 98% 98% 99% 99%                
 
